{"study_id": 101671, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of HMGB1 and its interaction with RAGE (receptor for advanced glycation end-products) in glioma development, progression, and treatment resistance.", "results_summary": "The study found that HMGB1, through binding to RAGE and other receptors, activates key signaling pathways influencing glioma cell growth, differentiation, motility, and apoptosis, with potential dual roles in promoting or suppressing tumor growth. It also discusses therapeutic approaches targeting HMGB1 to reduce chemoresistance in glioma cells.", "population_specificity": "Human gliomas (intracranial tumors)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:33.630614+00:00"}
{"study_id": 101672, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the pathophysiological link between type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD), focusing on shared mechanisms like advanced glycation end products (AGEs), to inform future treatment strategies.", "results_summary": "The study highlights the pathophysiological similarities between T2DM and AD, including the role of AGEs, and suggests that anti-diabetic drugs may help reduce cognitive decline in AD patients. It proposes that understanding these shared mechanisms could lead to more efficient management of both diseases.", "population_specificity": "Not specified (review of existing evidence, not a clinical trial).", "effective_dosage": "Not available.", "study_duration": "Not applicable (review study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:35.885154+00:00"}
{"study_id": 101673, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of the RAGE-pathway in sepsis, focusing on RAGE expression, soluble isoforms, and metabolic/immunologic ligands in inflammatory settings.", "results_summary": "RAGE expression and sRAGE plasma levels were significantly increased in septic shock patients compared to controls. Immunologic ligands (e.g., S100A8/A9) were elevated in sepsis, while metabolic ligands (e.g., AGE-CML) showed no significant difference or lower levels in later stages.", "population_specificity": "Patients with septic shock (n=60), postoperative controls (n=30), and healthy volunteers (n=30).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:36.234682+00:00"}
{"study_id": 101674, "supplement_id": 857, "safety_score": "20", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to review the formation of Advanced Glycation End Products (AGEs), their association with various diseases, and potential therapeutic agents to mitigate their effects.", "results_summary": "The study found that AGEs are linked to diabetes complications, atherosclerosis, aging, arthritis, cancer, and neurodegenerative diseases. Therapeutic agents targeting AGE formation and interaction with receptors were described, but none are clinically recommended.", "population_specificity": "Not specified (general review of existing research).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:37.944728+00:00"}
{"study_id": 101675, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of RAGE (receptor for advanced glycation end products) in astrocytes and its potential involvement in neurodegenerative disorders through proinflammatory activation.", "results_summary": "The study suggests that prolonged exposure to RAGE ligands or abnormally high concentrations may lead to chronic proinflammatory activation in astrocytes, potentially contributing to neurodegenerative disorders. Blocking or reducing RAGE/NF-\u03baB signaling in astrocytes could be a future therapeutic strategy for such disorders.", "population_specificity": "Not specified (focus on astrocytes and their role in the nervous system).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:38.253870+00:00"}
{"study_id": 101676, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 60, "study_goal": "The researchers aimed to summarize existing theories on the role of Advanced Glycation End Products (AGEs) in diabetic neuropathy pathogenesis and explore future treatment prospects.", "results_summary": "The study found that AGEs, along with other metabolic pathways, negatively influence nerve function and structure in diabetic neuropathy. While suppression of these pathways showed promise in animal models, clinical trials in humans did not yield satisfactory results.", "population_specificity": "Patients with diabetes (human and animal models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:39.796788+00:00"}
{"study_id": 101677, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in the etiopathogenesis of diabetic retinopathy, particularly their contribution to vascular dysfunction, inflammation, and angiogenesis.", "results_summary": "The study found that AGE accumulation, along with other mechanisms like polyol pathways and PKC activation, contributes to vascular dysfunction and inflammation in diabetic retinopathy, leading to vision loss. Hypoxia and VEGF overexpression further exacerbate these processes, promoting neovascularization and vasopermeability.", "population_specificity": "Patients with diabetic retinopathy (a microvascular complication of diabetes).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:41.618619+00:00"}
{"study_id": 101679, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in disease onset and complications, focusing on their mechanisms, receptor interactions (particularly RAGE), and potential therapeutic strategies.", "results_summary": "AGEs accumulate under hyperglycemic and oxidative stress conditions, contributing to diseases like cardiovascular disease, diabetes, and Alzheimer's. The study highlights RAGE as a mediator of inflammation and oxidative stress, suggesting it as a therapeutic target, with C. elegans proposed as a model for further research.", "population_specificity": "Not specified (general discussion of AGEs and their mechanisms).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:42.052616+00:00"}
{"study_id": 101678, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in the molecular mechanisms underlying diabetic nephropathy (DN).", "results_summary": "The study found that AGEs, along with other metabolic pathways, contribute to inflammatory processes and glomerulosclerosis in diabetic conditions, interacting with factors like oxidative stress and Rho-kinase.", "population_specificity": "Patients with diabetic nephropathy (DN).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:42.074448+00:00"}
{"study_id": 101680, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of S100B in binding to the receptor of advanced glycation end products (RAGE) and its implications in disease pathology and potential therapeutic targeting.", "results_summary": "The study found that S100B binds to RAGE, initiating multiple cell signaling pathways, and its levels may predict disease progression or prognosis in various conditions, suggesting its dual role as a biomarker and therapeutic target.", "population_specificity": "Not specified (broadly applicable to diseases like cerebrovascular, neurodegenerative, and infectious diseases).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:43.921286+00:00"}
{"study_id": 101682, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the dual role of DAMP molecules, particularly HMGB1 and its interaction with RAGE, in inflammation and tissue repair.", "results_summary": "The study found that HMGB1 interacts with RAGE and Toll-like receptors, playing a role in both inflammation and tissue repair, with potential therapeutic interventions targeting these pathways.", "population_specificity": "Not specified (review article)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:44.757328+00:00"}
{"study_id": 101681, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to assess the prevalence of subclinical arterial disease and hidden kidney disease, including the role of advanced glycation end products, and evaluate the impact of early diagnosis on cardiovascular morbidity and mortality.", "results_summary": "The abstract does not provide specific results regarding advanced glycation end products, as the study is ongoing with follow-up until 2025.", "population_specificity": "19,800 individuals aged 45-70 years without prior cardiovascular disease but with at least one cardiovascular risk factor, from primary health care centers in L\u00e9rida province.", "effective_dosage": "Not specified", "study_duration": "Follow-up until 2025 (intervention duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:44.834093+00:00"}
{"study_id": 101683, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare cardiovascular risk indicators, including skin autofluorescence (a marker of Advanced Glycation End Products), between stable COPD patients and smoking controls.", "results_summary": "Skin autofluorescence and aortic pulse wave velocity were significantly higher in COPD patients compared to controls, suggesting increased cardiovascular risk, but traditional CV risk prediction scores and sRAGE levels did not differ between groups.", "population_specificity": "Stable COPD patients (n = 185) and controls with a smoking history (n = 106).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:45.679110+00:00"}
{"study_id": 101684, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the role of SIRT1 in protecting podocytes from damage caused by advanced glycation end products (AGEs) in diabetic nephropathy.", "results_summary": "The study found that AGEs induce acetylation of p65 and STAT3 in human podocytes, leading to podocyte apoptosis and kidney injury. SIRT1 protects podocytes by deacetylating transcription factors and maintaining the actin cytoskeleton, thereby preventing glomerular injury.", "population_specificity": "Human podocytes (in vitro) and implications for diabetic nephropathy patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:47.558103+00:00"}
{"study_id": 101685, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of Advanced Glycation End Products (AGEs) in up-regulating LOX-1 and its implications for endothelial dysfunction and microvascular disorders.", "results_summary": "The study found that AGEs, along with other factors like oxLDL, up-regulate LOX-1, leading to endothelial dysfunction, oxidative stress, and microvascular inflammation. LOX-1 activation was associated with reduced NO-dependent vasodilation and increased IL-6 levels, contributing to atherosclerotic and microvascular diseases.", "population_specificity": "Human and animal models with metabolic disease and hypertension.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:50.141863+00:00"}
{"study_id": 101686, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to investigate the role of advanced glycation end products (RAGE) in diabetic macular edema and explore whether ascorbate repletion could mitigate RAGE-induced damage.", "results_summary": "The study found that RAGE activation contributes to oxidative stress and cellular damage in diabetic macular edema, while ascorbate showed potential in preventing apoptosis, preserving nitric oxide, and tightening the endothelial permeability barrier in cell culture studies.", "population_specificity": "Subjects with diabetes in poor glycemic control, particularly those with diabetic macular edema.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:50.460517+00:00"}
{"study_id": 101688, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if L-lysine could improve the structure and function of glycated lysozyme, reducing AGEs in patients with type 2 diabetes mellitus (T2DM).", "results_summary": "L-lysine reduced AGEs in both in vitro and in vivo conditions, improved lysozyme structure and function, and increased its bactericidal activity in T2DM patients.", "population_specificity": "Patients with type 2 diabetes mellitus (T2DM)", "effective_dosage": "3 g/day of L-lysine", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:51.493578+00:00"}
{"study_id": 101687, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the relationship between skin collagen Long Wavelength Fluorescence (LWF) as a marker for advanced glycation end-products (AGEs) and its association with glycemia, skin fluorescence, and the progression of complications in type 1 diabetes.", "results_summary": "The study found that LW-1 levels increased with age and diabetes duration and were significantly reduced by intensive glycemic therapy. LW-1 was independently associated with the progression of microvascular disease, intima-media thickness, and left ventricular mass in type 1 diabetes.", "population_specificity": "216 participants from the DCCT (Diabetes Control and Complications Trial) with type 1 diabetes.", "effective_dosage": "Not specified", "study_duration": "Measurements were taken at the end of the DCCT (1993) and during EDIC (Epidemiology of Diabetes Interventions and Complications) year 16.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:52.246717+00:00"}
{"study_id": 101689, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of RAGE activation by ligands like Advanced Glycation End Products (AGEs) in cancer progression and treatment resistance.", "results_summary": "The study suggests that RAGE activation by AGEs and other ligands contributes to tumor proliferation, invasiveness, metastasis, and treatment resistance, making them potential markers and therapeutic targets.", "population_specificity": "Cancer cells (in vitro or theoretical context, not specified in abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:52.368476+00:00"}
{"study_id": 101690, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the protective role of sulphoraphane against diabetic vascular complications, particularly its effects on oxidative stress and the AGE-RAGE axis.", "results_summary": "Sulphoraphane showed beneficial effects on vascular damage in cell cultures and diabetic animal models via antioxidative properties. It also inhibited AGE formation, reduced AGE-induced inflammation, and lowered serum AGE levels in humans.", "population_specificity": "Diabetic animal models and humans (specific population details not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:52.727968+00:00"}
{"study_id": 101691, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to review the cellular and molecular pathways mediating cardiac fibrosis in diabetes, focusing on the role of Advanced Glycation End Products (AGEs), and propose potential therapeutic interventions.", "results_summary": "The study found that AGEs contribute to cardiac fibrosis by crosslinking extracellular matrix proteins and activating fibrogenic signals through reactive oxygen species and RAGE-mediated pathways. Pro-inflammatory cytokines, transforming growth factor-\u03b2/Smad signaling, and other factors like adipokines and endothelin-1 were also implicated in diabetic myocardial fibrosis.", "population_specificity": "Individuals with type 1 and type 2 diabetes.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:54.750749+00:00"}
{"study_id": 101692, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether early statin treatment could reduce levels of Advanced Glycation End Products (TAGE) and other biomarkers, potentially offering cardioprotective effects in acute myocardial infarction (AMI) patients.", "results_summary": "The study found that early statin treatment suppressed TAGE levels and improved left ventricular function in AMI patients, though no significant differences were observed in major adverse cardiac and cerebrovascular events (MACCE).", "population_specificity": "Patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI).", "effective_dosage": "Atorvastatin (40 mg initial dose at admission, followed by 10 mg/day maintenance dose).", "study_duration": "30 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:56.623129+00:00"}
{"study_id": 101694, "supplement_id": 857, "safety_score": "20", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to summarize the pathophysiological role of dietary Advanced Glycation End Products (AGEs) in health and disease, particularly focusing on cardiometabolic disorders, and discuss their potential as therapeutic targets.", "results_summary": "The study found that AGEs contribute to oxidative stress, inflammation, and organ damage, accelerating aging- and diabetes-related disorders such as cardiovascular disease, chronic kidney disease, insulin resistance, and Alzheimer's disease. Dietary AGEs were identified as a major environmental source that exacerbates these conditions.", "population_specificity": "General physiological aging and hyperglycemic/oxidative stress conditions (not a specific clinical trial population).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:58.875584+00:00"}
{"study_id": 101695, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review recent advances and emerging techniques for detecting and quantifying Advanced Glycation End Products (AGEs) in vivo.", "results_summary": "The study highlights the importance of AGEs detection in understanding their role in diseases like diabetes and cardiovascular conditions. It identifies immunochemical approaches as the most effective but notes standardization challenges in current techniques.", "population_specificity": "Not specified (review of existing literature)", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:58.879234+00:00"}
{"study_id": 101693, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of enteric glial cells (EGCs) in neurogastroenterology, including their interactions with Advanced Glycation End Products (RAGE) signaling pathways, and their potential as therapeutic targets.", "results_summary": "The study highlights EGCs' involvement in neuroglial communication, inflammation, and gastrointestinal disorders, suggesting that targeting RAGE and related pathways (e.g., S100B, nitric oxide) may have therapeutic potential. Interventions like probiotics and interleukin-1 antagonists were noted as relevant clinical targets.", "population_specificity": "Not specified (review of basic, translational, and clinical studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:59.765093+00:00"}
{"study_id": 101696, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the structural and functional differences between low glycated (gHSA) and high glycated (AGE-HSA) human serum albumin and their effects on endothelial functionality.", "results_summary": "Low glycated gHSA enhanced long-lasting ROS production, while AGE-HSA caused earlier ROS production. Both increased mRNA levels of adhesion molecules, but only AGE-HSA increased protein levels and enhanced mononuclear cell adhesion to endothelial cells.", "population_specificity": "Human umbilical endothelial cells (HUVEC) and peripheral blood mononuclear cells (PBMC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:59.942007+00:00"}
{"study_id": 101697, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of autophagy, including modulation by Advanced Glycation End Products, in atherosclerosis and its potential as a therapeutic target.", "results_summary": "The abstract indicates that autophagy, influenced by Advanced Glycation End Products among other factors, plays dual protective and detrimental roles in atherosclerosis, but its precise mechanisms and relationship with apoptosis remain unclear. Recent studies suggest autophagy modulation as a potential therapeutic approach for atherosclerosis.", "population_specificity": "Not specified (focus on cellular mechanisms in endothelial cells, macrophages, and smooth muscle cells).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:37:59.944991+00:00"}
{"study_id": 101698, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to summarize the mechanisms of AGEs formation and accumulation, and evaluate pre-clinical and clinical experiences in anti-AGEs treatment for cardiovascular diseases.", "results_summary": "The study found that AGEs play a central role in diabetes-related complications and cardiovascular disease, with pharmacologic approaches against AGEs accumulation being investigated. Some drugs previously used for other conditions were found to have AGE-inhibitory effects, though clinical trial results were conflicting.", "population_specificity": "Diabetic (type 1 and type 2) and non-diabetic patients with cardiovascular disease risk.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:01.793241+00:00"}
{"study_id": 101699, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) as a mediator of hyperglycemia-induced cardiovascular complications, particularly in cardiac endothelial cells.", "results_summary": "The study found that AGEs play a crucial role in hyperglycemia-mediated detrimental effects on cardiac function, contributing to contractile dysfunction and exacerbating oxidative stress. Inhibition of AGEs was proposed as a novel therapeutic intervention for cardiovascular complications like acute myocardial infarction in hyperglycemic conditions.", "population_specificity": "Not specified (review article, no specific population studied)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:03.910537+00:00"}
{"study_id": 101700, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of S100/calgranulin proteins and their receptor RAGE in mediating vascular inflammation and atherosclerosis, and to explore potential therapeutic targets.", "results_summary": "The study found that S100A12 and the RAGE axis are important mediators of inflammation-induced atherosclerosis, with S100A12 emerging as a potential biomarker for coronary artery disease. Pharmacological inhibition of this pathway reduced atherosclerosis in mice, suggesting therapeutic potential.", "population_specificity": "Mice (transgenic and apolipoprotein E null) and humans (longitudinal population study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:04.777361+00:00"}
{"study_id": 101702, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to understand the role of Advanced Glycation End Products (AGEs) in macrovascular alterations in Type 2 diabetes mellitus (T2DM) patients, focusing on their impact on vascular smooth muscle cells (VSMCs) and related biomolecular pathways.", "results_summary": "The study found that AGEs, along with hyperglycemia, activate pathways like nuclear factor-\u03baB and MAPKs, leading to increased apoptotic susceptibility of VSMCs and extracellular matrix alterations in T2DM patients. Down-regulation of IGFR-1R activity and miR-133a levels further exacerbates these effects.", "population_specificity": "Patients with Type 2 diabetes mellitus (T2DM).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:07.428787+00:00"}
{"study_id": 101705, "supplement_id": 857, "safety_score": "30", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to explore the relationship between dietary Advanced Glycation End Products (AGEs) and inflammation, and assess the potential of dietary AGE restriction as a therapeutic strategy for chronic diseases.", "results_summary": "The study found that AGEs contribute to inflammation and chronic diseases via interaction with the receptor for AGEs, but evidence from human studies on the benefits of dietary AGE restriction remains unclear. Animal models showed reduced inflammation with AGE restriction.", "population_specificity": "Not specified (abstract mentions animal models and general human implications).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:07.548894+00:00"}
{"study_id": 101701, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify key proteins linked to diabetic retinopathy progression, focusing on inflammation, complement, and coagulation pathways, to inform therapeutic development.", "results_summary": "The study identified 230 proteins with significantly higher abundance in proliferative diabetic retinopathy, linked to inflammation, complement, coagulation, and cellular adhesion, highlighting the disease's multifactorial nature.", "population_specificity": "Patients with nonproliferative or proliferative diabetic retinopathy, including some treated with anti-VEGF (bevacizumab).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:07.601207+00:00"}
{"study_id": 101703, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the formation, structural consequences, and clinical implications of Advanced Glycation End Products (AGEs) in relation to diabetic complications, neurodegeneration, and vascular disease.", "results_summary": "The study found that AGE-modified albumin is linked to diabetic complications, neurodegeneration, and vascular disease, and discussed its role in proinflammatory signaling and drug binding. It also compared analytical methods for detecting AGEs and evaluated glycated albumin as a clinical marker for glycemic control.", "population_specificity": "Poorly controlled diabetics and general implications for populations at risk of AGE-related complications.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:07.959724+00:00"}
{"study_id": 101704, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore the potential mechanisms behind the negative association between diabetes mellitus and abdominal aortic aneurysm formation, focusing on the role of advanced glycation end products.", "results_summary": "The study suggests that advanced glycation end products may contribute to increased arterial wall matrix formation, reduced MMP activity, and diminished macrophage infiltration, potentially offering modest protection against AAA formation. However, the effects of pharmacological agents used in diabetes treatment on AAA formation remain controversial.", "population_specificity": "Patients with diabetes mellitus and potential risk for abdominal aortic aneurysms.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:08.838208+00:00"}
{"study_id": 101706, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of MT1-MMP in signaling pathways involving Advanced Glycation End Products (AGEs) and its potential as a therapeutic target for diabetic vascular complications.", "results_summary": "The study found that MT1-MMP contributes to reactive oxygen species (ROS) generation via AGE receptor activation in smooth muscle cells, suggesting its involvement in diabetic vascular complications. Additionally, MT1-MMP-mediated signaling pathways, including RhoA/Rac1 activation and NF-\u03baB phosphorylation, were implicated in endothelial dysfunction and inflammation.", "population_specificity": "Smooth muscle cells and endothelial cells (in vitro or animal models, not explicitly stated).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:10.757312+00:00"}
{"study_id": 101707, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in oxidative stress and vascular diseases, particularly their link to diabetes through the AGE/RAGE axis impairment.", "results_summary": "The study found that AGEs contribute to oxidative stress and vascular dysfunction, particularly in diabetes, through mechanisms like AGE/RAGE axis impairment, PKC, AR, and NOX dysfunction. Oxidative stress biomarkers, including ROS-modified compounds, were highlighted as tools to understand vascular disease mechanisms.", "population_specificity": "Not specified (review article, no specific population studied)", "effective_dosage": "Not available", "study_duration": "Not applicable (review article)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:11.560112+00:00"}
{"study_id": 101708, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the harmful effects of Advanced Glycation End Products (AGEs) in chronic kidney disease (CKD) and their role in cardiovascular complications and diabetic nephropathy, as well as potential therapeutic strategies targeting the AGE-RAGE axis.", "results_summary": "The study found that AGEs contribute to oxidative stress, inflammation, and cardiovascular complications in CKD, with higher levels due to increased formation and reduced renal clearance. Potential pharmacologic approaches to mitigate these effects include reducing AGE sources, enhancing their breakdown, or inhibiting AGE-induced inflammation.", "population_specificity": "Patients with chronic kidney disease (CKD), particularly those with diabetic nephropathy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:13.435573+00:00"}
{"study_id": 101709, "supplement_id": 857, "safety_score": "65", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review literature on AGEs inhibitors, focusing on their chemical structures, mechanisms of action, pharmacokinetics, and therapeutic potential in treating diseases like diabetes and Alzheimer's.", "results_summary": "The study found that several AGEs inhibitors show potent antiglycation activity with minimal side effects, though concerns remain about low effectiveness and poor pharmacokinetics. These inhibitors could serve as scaffolds for developing new clinical agents.", "population_specificity": "Not specified (literature review of patents and studies from 2001-2014).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:16.808524+00:00"}
{"study_id": 101710, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to describe the levels of main RAGE isoforms and ligands, including Advanced Glycation End Products (AGEs), during ARDS and their association with disease severity and lung morphology.", "results_summary": "ARDS patients had lower levels of AGEs compared to controls, and baseline arterial AGEs were associated with disease severity as assessed by PaO2/FiO2. Elevated sRAGE, HMGB1, and S100A12, along with decreased esRAGE and AGEs, distinguished ARDS patients from controls.", "population_specificity": "30 ARDS patients and 30 mechanically ventilated controls.", "effective_dosage": "Not specified", "study_duration": "Measurements taken on day 0, day 3, and day 6.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:17.730481+00:00"}
{"study_id": 101712, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in diabetic nephropathy (DN) and identify potential therapeutic targets using in vitro models.", "results_summary": "The abstract highlights that AGEs contribute to proximal tubule damage in DN through dysregulated pathways, but it does not report specific findings on AGEs' effects. The RPTEC/TERT1 cell line is proposed as a promising model for further research.", "population_specificity": "In vitro proximal tubular cell lines (e.g., RPTEC/TERT1)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:17.843955+00:00"}
{"study_id": 101711, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the role of advanced glycation end products (AGEs) in arteriosclerosis (AS) after kidney transplantation and explore the molecular mechanisms involved, particularly the AGE/RAGE/ILK pathway.", "results_summary": "The study found significant differences in serum AGEs, histological changes, and expression of \u03b1-SMA and OPN between healthy volunteers and renal transplant recipients. AGEs induced VSMCs-to-osteoblast trans-differentiation via the AGE/RAGE/ILK pathway, suggesting a critical role in AS progression post-transplantation.", "population_specificity": "30 healthy volunteers and 30 renal transplant recipients (RTRs), with additional in vitro analysis using rat vascular smooth muscle cells (VSMCs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:18.296590+00:00"}
{"study_id": 101713, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the interactions between the RAGE and incretin pathways and assess the potential clinical benefits of targeting the GLP-1/incretin pathway in diabetic nephropathy.", "results_summary": "The study suggests that aberrant RAGE activation contributes to diabetic nephropathy via inflammation and fibrosis, and that GLP-1 may interfere with RAGE signaling, offering renoprotective effects in rodent models of diabetes.", "population_specificity": "Rodent models of diabetes (specific human population not mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:18.809576+00:00"}
{"study_id": 101715, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the role of the receptor for advanced glycation end products (RAGE) in Alzheimer's disease (AD) pathophysiology and its potential as a therapeutic target.", "results_summary": "The study found that RAGE contributes to A\u03b2 production, accumulation, and neurotoxicity, while also impairing synaptic function and promoting tau hyper-phosphorylation. However, soluble RAGE (sRAGE) interactions may mitigate A\u03b2 neurotoxicity and enhance clearance, suggesting RAGE inhibitors could be a promising AD treatment.", "population_specificity": "Not specified (focus on preclinical and clinical studies related to Alzheimer's disease).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:22.160029+00:00"}
{"study_id": 101716, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to investigate the association between vitamin D status and skin autofluorescence (a marker of advanced glycation end products) in patients with type 2 diabetes mellitus.", "results_summary": "Skin autofluorescence was higher in patients with low vitamin D levels, and vitamin D status was independently associated with skin autofluorescence. However, vitamin D supplementation over 6 months did not reduce skin AGE accumulation compared to placebo.", "population_specificity": "245 patients with well-controlled type 2 diabetes mellitus treated with lifestyle advice, metformin, and/or sulphonylurea-derivatives.", "effective_dosage": "50,000 IU/month of vitamin D", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:23.852393+00:00"}
{"study_id": 101717, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether combining hemodialysis (HD) and hemoperfusion (HP) could effectively remove circulating advanced glycation end products (AGEs) in patients with end-stage renal disease.", "results_summary": "The study found that HD alone did not reduce serum AGEs, but the combined HP + HD treatment significantly lowered AGEs and TNF-\u03b1 levels. The results suggest that HP + HD is more effective than HD alone for removing protein-bound uremic toxins and inflammatory cytokines.", "population_specificity": "Thirty-six patients undergoing maintenance hemodialysis for end-stage renal disease.", "effective_dosage": "Not specified (treatment involved HD followed by HP + HD or vice versa).", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:26.437490+00:00"}
{"study_id": 101719, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to understand the role of advanced glycation end products (AGEs) in cellular senescence and their contribution to age-related kidney dysfunction and diabetic nephropathy.", "results_summary": "The study found that AGEs, along with intracellular glucose and endoplasmic reticulum stress, contribute to cellular senescence, which plays a key role in kidney aging and disease progression. It also highlighted the use of telomere length as a biomarker for senescence in clinical studies.", "population_specificity": "Aging individuals and those with chronic kidney disease or diabetic nephropathy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:26.554290+00:00"}
{"study_id": 101721, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of advanced glycation end products (AGEs) in glycemic memory and their contribution to diabetic vascular complications.", "results_summary": "The study found that oxidative stress and AGE accumulation are key drivers of glycemic memory in endothelial cells, with epigenetic marks also closely associated. Endothelial progenitors, negatively impacted by diabetes, may act as carriers of glycemic memory, suggesting potential for future epigenetics-based therapies.", "population_specificity": "Diabetic patients, particularly those with vascular complications.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:26.619536+00:00"}
{"study_id": 101718, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of soluble receptor for advanced glycation end products (sRAGE) as a biomarker for emphysema in COPD and its potential as a therapeutic target.", "results_summary": "The study found that sRAGE is linked to COPD, particularly emphysema, and likely plays a mechanistic role. Evidence suggests sRAGE acts as a decoy for RAGE ligands, potentially mitigating inflammation, making it a promising biomarker and therapeutic target.", "population_specificity": "Patients with chronic obstructive pulmonary disease (COPD), specifically the emphysema subpopulation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:26.742001+00:00"}
{"study_id": 101720, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of Advanced Glycation End Products (AGEs) in the molecular changes contributing to diabetic macular oedema (DMO) and assess current and potential treatments, including combination therapies.", "results_summary": "The study identified AGEs as part of the pro-inflammatory molecular changes that increase vascular permeability in DMO, contributing to fluid leakage and macular oedema. Current treatments targeting VEGF or non-VEGF pathways, including anti-VEGFs and steroids, do not fully resolve the condition, suggesting a need for combination therapies addressing underlying pathology.", "population_specificity": "Diabetic patients with macular oedema.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:27.498978+00:00"}
{"study_id": 101722, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of the Receptor for Advanced Glycation End-products (RAGE) in cancer progression, including its effects on cell proliferation, angiogenesis, survival, and anti-apoptosis.", "results_summary": "The study found that RAGE enhances cancer cell proliferation by activating cell cycle proteins (e.g., cyclin D1), anti-apoptotic proteins (e.g., BCl2), and prosurvival pathways (e.g., AKT). It also plays a role in angiogenesis and activation of myeloid-derived suppressor cells (MDSCs), complicating cancer progression.", "population_specificity": "Mouse models (RAGE-deficient mice) and inflammation-associated carcinogenesis models (chemically induced carcinogenesis and colitis-associated cancer).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:31.094729+00:00"}
{"study_id": 101723, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in the pathophysiology of schizophrenia and their potential link to cardiovascular disease.", "results_summary": "The study identified AGEs as metabolic biomarkers of oxidative stress with pathogenic roles in schizophrenia and other oxidative stress-related diseases. It highlighted AGE formation, accumulation, and RAGE activation as contributors to inflammatory pathways and disease progression.", "population_specificity": "Individuals with schizophrenia and oxidative stress-related diseases (e.g., atherosclerosis, diabetes, neurodegenerative disorders).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:31.631457+00:00"}
{"study_id": 101725, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine if sRAGE is a useful biomarker in AMI patients receiving remote ischaemic conditioning.", "results_summary": "sRAGE levels did not differ between patients receiving remote ischaemic conditioning and controls, nor did they reflect increased myocardial salvage index. However, sRAGE levels increased with higher NYHA classification after 30 days.", "population_specificity": "191 patients with ST-elevation myocardial infarction (STEMI) treated with primary percutaneous intervention (pPCI).", "effective_dosage": "Not specified", "study_duration": "30 days follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:34.535262+00:00"}
{"study_id": 101726, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to summarize the pathological role of RAGE in various liver disorders and explore its potential as a therapeutic target.", "results_summary": "The study found that RAGE activation contributes to oxidative stress and liver disease progression, suggesting that inhibiting the RAGE pathway could be a novel therapeutic approach for hepatic disorders.", "population_specificity": "Hepatic stellate cells, hepatocytes, and hepatoma cells (in vitro or animal models implied, not explicitly stated).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:35.012593+00:00"}
{"study_id": 101724, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in platelet activation and inflammation, and their contribution to atherothrombosis in type 2 diabetes mellitus (T2DM).", "results_summary": "The study found that AGEs, particularly through soluble receptor for advanced glycation-end-products (sRAGE), may amplify inflammation by promoting cytokine release and cell activation, contributing to platelet dysfunction and atherothrombosis in diabetic subjects. It also highlighted the limitations of standard antiplatelet therapies like aspirin in this population.", "population_specificity": "Patients with type 2 diabetes mellitus (T2DM), including those in early stages or preclinical phases of glucose metabolism impairment.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:35.348589+00:00"}
{"study_id": 101727, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in the development of distinct diabetic cardiomyopathy phenotypes (restrictive/HFPEF and dilated/HFREF).", "results_summary": "The study found that AGE deposition is relevant to both diabetic cardiomyopathy phenotypes but did not quantify its specific effects or efficacy. It highlighted AGEs as a contributing factor alongside other metabolic derangements and autoimmunity.", "population_specificity": "Patients with diabetes mellitus (type 1 and type 2) and related cardiomyopathy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:35.459025+00:00"}
{"study_id": 101728, "supplement_id": 857, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the role of advanced glycation end products (AGEs) in oxidative stress and chronic inflammation, and the effects of an AGE-restricted diet on systemic AGE levels and inflammatory markers.", "results_summary": "The study found that AGEs contribute to oxidative stress and chronic inflammation, and an AGE-restricted diet reduces systemic AGE levels and markers of inflammation, particularly in chronic kidney disease (CKD) patients, with or without diabetes.", "population_specificity": "CKD patients before and after dialysis initiation, with or without coexistent diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:36.155710+00:00"}
{"study_id": 101729, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of the complement system and complement regulatory proteins, particularly CD59, in the pathogenesis of diabetic vascular complications linked to Advanced Glycation End Products.", "results_summary": "The study found that glycation-induced inactivation of CD59 and hyperglycemia-driven complement activation increase MAC deposition, leading to inflammation, proliferation, and thrombosis in diabetic complications. It supports a pathogenic model combining complement-dependent and complement-independent mechanisms in diabetes-related organ damage.", "population_specificity": "Human diabetes (focus on vascular complications)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:38.645217+00:00"}
{"study_id": 101730, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine the mRNA levels of S100A12 and RAGE in bladder transitional cell carcinoma (TCC) patients to assess their potential as biomarkers.", "results_summary": "The study found that mRNA expression of S100A12 and RAGE was significantly up-regulated in bladder TCC tissues compared to normal urothelium, suggesting their potential as diagnostic or monitoring biomarkers.", "population_specificity": "Male patients with bladder transitional cell carcinoma (TCC).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:39.001835+00:00"}
{"study_id": 101731, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the process of protein glycation, identify potential inhibitors (antiglycation agents) from natural and synthetic sources, and evaluate their mechanisms of action in vitro and in vivo.", "results_summary": "The review highlighted various compounds (e.g., flavonoids, alkaloids, terpenes) that inhibit protein glycation and AGE formation, suggesting antiglycation therapy as a future strategy to manage diabetic complications.", "population_specificity": "Not specified (general focus on diabetic complications).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:42.127291+00:00"}
{"study_id": 101732, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of CTGF in diabetic retinopathy pathogenesis, particularly its relationship with advanced glycation end products (AGEs) and potential as a therapeutic target.", "results_summary": "The study found that CTGF, induced by AGEs and growth factors like VEGF and TGF-\u03b2, contributes to fibrotic responses in diabetic retinopathy, including ECM remodeling, BL thickening, and pericyte loss. It also drives the angio-fibrotic switch in PDR, suggesting CTGF as a potential therapeutic target.", "population_specificity": "Patients with diabetic retinopathy (pre-clinical and proliferative stages).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:42.691141+00:00"}
{"study_id": 101734, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in the pathogenesis of Type 2 Diabetes Mellitus (T2DM) and diabetic complications, assessing whether they are causal or merely an effect.", "results_summary": "The study found that AGEs contribute to oxidative stress and tissue injury in hyperglycemia, potentially playing a role in T2DM development and complications. However, the exact causal relationship remains unclear.", "population_specificity": "Not specified (general discussion of T2DM and diabetic complications).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:42.781153+00:00"}
{"study_id": 101733, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether serum sRAGE levels are related to weight loss and insulin resistance improvement in obese subjects following a very low-calorie diet (VLCD).", "results_summary": "Lower baseline sRAGE levels were significantly associated with greater BMI reduction and improved insulin resistance. Changes in sRAGE levels during the intervention correlated with changes in BMI, suggesting sRAGE as a potential biomarker for predicting dietary intervention outcomes.", "population_specificity": "22 severely obese subjects (median BMI: 44.5 kg/m\u00b2).", "effective_dosage": "800 kcal/day (VLCD phase).", "study_duration": "6 months (12 weeks VLCD, 12 weeks weight maintenance).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:43.450546+00:00"}
{"study_id": 101735, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether cilostazol improves peripheral arterial occlusion disease (PAOD) severity in type 2 diabetic patients by increasing plasma sRAGE levels.", "results_summary": "Cilostazol significantly increased plasma sRAGE, improved ankle-brachial index (ABI), and reduced inflammatory markers (hsCRP, sVCAM-1, E-selectin). The change in sRAGE correlated with ABI improvement, suggesting sRAGE as an independent predictor of PAOD severity reduction.", "population_specificity": "90 type 2 diabetic patients with PAOD (intermittent claudication and ABI \u22640.9).", "effective_dosage": "100 mg twice daily.", "study_duration": "52 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:44.815046+00:00"}
{"study_id": 101736, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not address Advanced Glycation End Products; it focuses on tamoxifen resistance in premenopausal breast cancer.", "results_summary": "The abstract does not discuss Advanced Glycation End Products.", "population_specificity": "Premenopausal breast cancer patients with estrogen receptor-positive tumors.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:45.449464+00:00"}
{"study_id": 101737, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of HMGB1 and its receptors, including advanced glycation end-products, in the pathogenesis of severe acute pancreatitis (SAP).", "results_summary": "The study found that extracellular HMGB1 exacerbates pancreatic inflammation, while intracellular HMGB1 has protective effects. Receptors for advanced glycation end-products and toll-like receptors (TLR-2, TLR-4) mediate HMGB1-triggered inflammation, suggesting potential therapeutic targets for SAP.", "population_specificity": "Not specified (general focus on mammalian models or inflammatory disease contexts).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:47.234340+00:00"}
{"study_id": 101740, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the role of AGE-albumin in Parkinson's disease pathogenesis and its potential as a diagnostic and therapeutic biomarker.", "results_summary": "The study found that AGE-albumin, synthesized by activated microglial cells, accumulates in PD brains and contributes to dopamine neuron apoptosis. Treatment with soluble receptor to AGE reduced neuronal death in animal models.", "population_specificity": "Human PD brains and animal models (specific species not mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:49.950165+00:00"}
{"study_id": 101738, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to discuss the role of microRNAs in regulating the AGE/RAGE pathway and their potential as therapeutic targets for diabetic complications.", "results_summary": "The study found that AGEs contribute to diabetic complications by inducing oxidative stress, mitochondrial dysfunction, and inflammatory responses via the AGE/RAGE pathway, with microRNAs identified as potential regulators of this process.", "population_specificity": "Diabetic patients with micro- and macrovascular complications.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:50.458516+00:00"}
{"study_id": 101739, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in diabetes-associated disorders and the potential therapeutic intervention via the AGEs-RAGE axis and DPP-4-incretin system.", "results_summary": "The study found that AGEs contribute to oxidative stress, inflammation, and fibrosis, accelerating diabetes-related complications like microangiopathy and cardiovascular diseases. It also highlighted the potential of DPP-4 inhibition and GLP-1 analogues as therapeutic targets for these disorders.", "population_specificity": "Not specified (general focus on diabetes-associated disorders).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:51.292167+00:00"}
{"study_id": 101742, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in the pathogenesis of diabetic erectile dysfunction (DED) among men with diabetes.", "results_summary": "The abstract identifies AGEs as one of the contributing factors in diabetic neuropathy, which plays a role in DED, but does not provide specific findings on AGEs' direct effects or interventions targeting them.", "population_specificity": "Men with diabetes experiencing erectile dysfunction.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:52.301526+00:00"}
{"study_id": 101741, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the relationship between plasma levels of sRAGE (a soluble receptor for advanced glycation end products) and the risk of recurrent major cardiovascular events in patients with stable coronary heart disease treated with atorvastatin.", "results_summary": "The study found that higher plasma levels of sRAGE were predictive of recurrent major cardiovascular events, even after adjusting for confounding factors like diabetes, hypertension, smoking, and BMI. The association remained statistically significant, suggesting sRAGE may be a useful biomarker for cardiovascular risk in this population.", "population_specificity": "Patients with stable coronary heart disease (CHD) treated with atorvastatin.", "effective_dosage": "Not specified for sRAGE; atorvastatin doses were 10 mg and 80 mg.", "study_duration": "4.9 years of study follow-up.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:53.032708+00:00"}
{"study_id": 101743, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers were evaluating the potential of an AD-specific IVIG, including antibodies targeting Advanced Glycation End Products, to slow Alzheimer's disease progression compared to standard IVIG.", "results_summary": "Phase II and III studies with IVIG did not show slowing of AD progression compared to placebo, contrasting earlier pilot studies. An AD-specific IVIG with enriched antibodies, including those targeting Advanced Glycation End Products, was proposed as a potentially more effective alternative, though preclinical validation and regulatory hurdles remain.", "population_specificity": "Patients with Alzheimer's disease", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:53.170025+00:00"}
{"study_id": 101744, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to summarize the pathological role of AGEs and RAGE activation in tumor growth and metastasis, and explore potential therapeutic interventions.", "results_summary": "The study found that AGEs accumulate in tissues during aging and hyperglycemic conditions, interacting with RAGE to promote oxidative stress, inflammation, and cancer progression. These findings suggest AGEs and RAGE signaling may explain increased cancer risk in diabetic and elderly populations.", "population_specificity": "General aging population and individuals with hyperglycemic/oxidative stress conditions (e.g., diabetes).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:55.700373+00:00"}
{"study_id": 101714, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers investigated whether immunoparalysis develops after cardiac arrest and if danger-associated molecular patterns, including Advanced Glycation End Products (EN-RAGE), are involved.", "results_summary": "The study found that post-cardiac arrest patients exhibited immunoparalysis, with impaired cytokine production, and elevated levels of danger-associated molecular patterns (including EN-RAGE), which correlated with reduced immune function.", "population_specificity": "Fourteen post-cardiac arrest patients treated with mild therapeutic hypothermia and 11 control subjects.", "effective_dosage": "Not specified", "study_duration": "24 hours of therapeutic hypothermia, with follow-up over 2 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:57.190613+00:00"}
{"study_id": 101745, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in the pathophysiology of diabetic retinopathy (DR).", "results_summary": "The study found that AGEs formation is one of the biochemical changes induced by hyperglycemia, contributing to the microvascular damage in DR. It also highlighted the involvement of inflammation and neurodegeneration in DR pathogenesis.", "population_specificity": "Patients with diabetes, particularly those at risk for or with diabetic retinopathy.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:57.736917+00:00"}
{"study_id": 101746, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to describe the clinical impact of diabetes mellitus (DM) on cognitive dysfunction and explore potential therapeutic avenues for managing this condition.", "results_summary": "The study found that DM, both type 1 and type 2, is associated with cognitive dysfunction, accelerated cerebral atrophy, and heightened white matter abnormalities, particularly affecting attention, executive function, processing speed, perception, and memory. It also highlighted DM's potential to exacerbate neurodegenerative processes like Alzheimer's disease.", "population_specificity": "Individuals with type 1 or type 2 diabetes mellitus, particularly at the extremes of life (childhood and advanced age).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:58.824590+00:00"}
{"study_id": 101747, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of Nox-4 in kidney diseases, including its involvement in damage induced by advanced glycation end-products (AGEs) and other pathways.", "results_summary": "The study found that Nox-4 is implicated in kidney damage, particularly in diabetic nephropathy, and is linked to pathways involving AGEs, hyperglycemia, and other renal damage mechanisms. Preclinical data suggest potential benefits of Nox-4 inhibition, though its role as a therapeutic target remains controversial.", "population_specificity": "Not specified (focus on preclinical and mechanistic research).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:38:59.652152+00:00"}
{"study_id": 101749, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the association between genetic polymorphisms, including those related to the receptor for advanced glycation end products (RAGE), and peritoneal membrane solute transport and clinical outcomes in peritoneal dialysis (PD) patients.", "results_summary": "The study found associations between polymorphisms in the RAGE gene and peritoneal membrane solute transport, suggesting a genetic influence on membrane characteristics in PD patients. However, the evidence was less consistent compared to other genes like IL-6.", "population_specificity": "Peritoneal dialysis (PD) patients", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:00.550975+00:00"}
{"study_id": 101750, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to determine whether preventing hyperglycemia during critical illness reduces excessive RAGE signaling and its association with clinical outcomes and mortality.", "results_summary": "Elevated soluble RAGE on admission was associated with adverse outcomes, including circulatory and kidney failure, but insulin treatment did not affect circulating levels of RAGE-related markers. Critical illness altered RAGE signaling components, which remained unaffected by insulin therapy.", "population_specificity": "405 long-stay surgical intensive care unit patients and 71 matched control subjects.", "effective_dosage": "Not specified", "study_duration": "Measurements taken on admission, day 7, and last day of ICU stay.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:00.969180+00:00"}
{"study_id": 101748, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the association between proximal tubule dysfunction and podocyte damage biomarkers in Type 2 diabetes mellitus, particularly focusing on the role of advanced glycation end-products in early diabetic nephropathy.", "results_summary": "The study found significant correlations between proximal tubule dysfunction markers (alpha1-microglobulin and kidney injury molecule-1) and podocyte damage biomarkers (nephrin and vascular endothelial growth factor), as well as advanced glycation end-products, suggesting their potential role in early diabetic nephropathy. These associations were observed even in normoalbuminuric patients.", "population_specificity": "Type 2 diabetes mellitus outpatients (38 normoalbuminuric, 32 microalbuminuric) and 21 healthy subjects.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:01.170010+00:00"}
{"study_id": 101751, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to understand the physiological roles and potential clinical value of polyphenol consumption, including its effects on advanced glycation end products, in the context of reproductive health and pregnancy.", "results_summary": "Polyphenols regulate key targets related to oxidative stress, inflammation, and advanced glycation end products, with implications for obstetrical complications such as pre-eclampsia and preterm birth. However, the study highlights the need for further research to clarify safe consumption levels during pregnancy.", "population_specificity": "General and reproductive health contexts, including pregnancy-related outcomes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:03.621033+00:00"}
{"study_id": 101753, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the role of autophagy in diabetic kidney injury, focusing on the impact of advanced glycation end-products (AGEs) and other metabolic stressors in the development of diabetic nephropathy.", "results_summary": "The study found that impairment of autophagy contributes to diabetic nephropathy, and targeting autophagy may be renoprotective. AGEs, oxidative stress, and other metabolic disturbances modulate autophagy and play a role in kidney injury.", "population_specificity": "Renal cells in culture, human kidney tissues, and experimental animal models of diabetes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:06.678006+00:00"}
{"study_id": 101752, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of advanced glycation end products (AGEs) in the pathogenesis of idiopathic epiretinal membrane (iERM), particularly their contribution to anomalous posterior vitreous detachment and fibrotic tissue contraction.", "results_summary": "The study suggests that AGE accumulation, associated with aging, may contribute to anomalous posterior vitreous detachment and influence the mechanical properties of iERM, potentially playing a role in its fibrotic remodeling. No direct efficacy or safety outcomes of AGEs were reported.", "population_specificity": "Individuals with idiopathic epiretinal membrane (iERM), particularly those with age-related changes.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:07.156849+00:00"}
{"study_id": 101754, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of pioglitazone on the progression from persistent to permanent atrial fibrillation in diabetes mellitus patients and explore the role of advanced glycation end products (AGEs) in this process.", "results_summary": "Pioglitazone treatment significantly reduced AGE levels at 6 and 14 months and was associated with a lower incidence of permanent atrial fibrillation compared to placebo. The study suggests that pioglitazone's suppression of AGEs may contribute to its beneficial effects.", "population_specificity": "146 diabetes mellitus patients with newly identified persistent atrial fibrillation.", "effective_dosage": "30 mg/day", "study_duration": "14 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:07.576398+00:00"}
{"study_id": 101755, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of galectin-3 in the pathogenesis of diabetic complications via its interaction with advanced glycation end-products (AGEs) and advanced lipoxidation end-products (ALEs).", "results_summary": "The study found that galectin-3 plays a dual role in AGE/ALE-related damage, impairing their removal in some organs (e.g., kidney and vessels) while reducing uptake and tissue accumulation in others (e.g., liver). It also suggested galectin-3 may exert AGE/ALE-independent effects, such as modulating inflammation and fibrogenesis.", "population_specificity": "Not specified (focus on biological mechanisms rather than a specific human population).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:08.466529+00:00"}
{"study_id": 101757, "supplement_id": 857, "safety_score": "40", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to examine the relationship between dietary intake of Advanced Glycation End Products (AGEs) and inflammatory processes, as well as their potential impact on chronic diseases.", "results_summary": "The study found that a low-AGE diet was associated with decreased inflammation, while a high-AGE diet showed less consistent increases in inflammation. Observational studies suggested a link between dietary AGEs and inflammatory status, but further research is needed in healthy populations.", "population_specificity": "Primarily patients with chronic kidney disease or diabetes, with limited data on healthy individuals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:10.121413+00:00"}
{"study_id": 101756, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether serum levels of Advanced Glycation End Products (AGE) were elevated in non-B or non-C hepatocellular carcinoma (NBNC-HCC) patients compared to NASH subjects without HCC and identify independent determinants of AGE levels.", "results_summary": "Serum AGE levels were significantly higher in NBNC-HCC patients compared to NASH and control subjects. AGE levels were independently associated with age, GGT, and HDL-cholesterol (inversely), suggesting AGE might play a role in NBNC-HCC pathogenesis and serve as a biomarker.", "population_specificity": "NBNC-HCC patients (n=90), NASH subjects without HCC (n=56), and control subjects (n=27).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:10.293708+00:00"}
{"study_id": 101759, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of Advanced Glycation End Products (AGEs) and their receptors (RAGE and sRAGE) in the development of cardiovascular disease (CVD) in menopausal women.", "results_summary": "The study found that AGEs and their receptors contribute to oxidative stress, inflammation, endothelial cell toxicity, and atherosclerosis progression in menopause, with RAGE and sRAGE levels linked to CVD risk factors like adiposity, dyslipidemia, and insulin resistance. Pharmacological targeting of the AGE-RAGE pathway shows therapeutic potential for CVD in this population.", "population_specificity": "Postmenopausal women", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:12.577370+00:00"}
{"study_id": 101760, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of HMGB1, particularly its interaction with the receptor for advanced glycation end products (RAGE), in the induction and maintenance of hypersensitivity in experimental models of chronic pain.", "results_summary": "The study found that HMGB1 acts as a proinflammatory mediator and contributes to persistent pain by interacting with RAGE and Toll-like receptors, suggesting potential therapeutic benefits of targeting HMGB1 in chronic pain conditions.", "population_specificity": "Experimental models of pain (not specified if human or animal).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:15.283528+00:00"}
{"study_id": 101762, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to review pharmacological options, including Advanced Glycation End Products (AGE) cross-link breakers, for reducing arterial stiffness.", "results_summary": "The abstract indicates that AGE cross-link breakers, among other drug groups, have shown some effect in decreasing arterial stiffness, though further studies are needed to assess their impact on major adverse cardiovascular and cerebrovascular events (MACCE).", "population_specificity": "Not specified (general aging population with arterial stiffness implied).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:16.166387+00:00"}
{"study_id": 101761, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether additional advanced glycation end products (AGEs) improve associations with microvascular complications (retinopathy, nephropathy, neuropathy) in diabetes patients, independent of A1C levels.", "results_summary": "The complete 10-AGE panel significantly correlated with worsening retinopathy, microalbuminuria, and neuropathy, independent of A1C levels. Glucosepane (GSPNE) and fructose-lysine (FUR) emerged as key risk factors, enhancing associations with retinopathy and neuropathy progression.", "population_specificity": "Diabetes patients from the Diabetes Control and Complications Trial (DCCT) and Epidemiology of Diabetes Interventions and Complications (EDIC) study.", "effective_dosage": "Not specified", "study_duration": "13-17 years after DCCT closeout", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:16.793284+00:00"}
{"study_id": 101763, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to summarize recent findings on the role of Advanced Glycation End Products (AGEs) in chronic kidney disease (CKD) progression and explore potential therapeutic strategies.", "results_summary": "The study highlights AGEs' detrimental role in CKD, particularly diabetic nephropathy, but notes limited human studies or clinical trials demonstrating that inhibiting AGEs ameliorates disease. Recent research focuses on novel mechanisms of AGE-induced injury and potential therapeutic targets.", "population_specificity": "Chronic kidney disease (CKD) patients, particularly those with diabetic nephropathy.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:17.811755+00:00"}
{"study_id": 101764, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the mechanisms contributing to bone fragility in patients with type 2 diabetes mellitus (T2DM), focusing on the role of advanced glycation end-products (AGEs) in collagen deterioration and bone quality.", "results_summary": "The study found that AGEs contribute to bone fragility in T2DM patients by deteriorating collagen and altering bone turnover and micro-architecture, despite normal or increased bone mineral density. Fracture risk in these patients is influenced by disease duration, severity, metabolic control, and therapy type, but traditional risk assessment tools like BMD and FRAX are less predictive.", "population_specificity": "Patients with type 2 diabetes mellitus (T2DM).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:19.406837+00:00"}
{"study_id": 101765, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the pathway of AGE formation, their role in neurodegenerative diseases, and potential therapeutic approaches to mitigate their effects.", "results_summary": "The study found that glycation leads to the formation of \u03b2-sheet structures in proteins, causing aggregation linked to neurodegenerative diseases like Alzheimer's and Parkinson's. It also highlighted the toxicity of oligomeric species of glycated proteins and discussed therapeutic inhibitors and the AGE-RAGE axis as promising preventive measures.", "population_specificity": "Not specified (review of molecular mechanisms and therapeutic approaches).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:19.460601+00:00"}
{"study_id": 101758, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of Advanced Glycation End Products (AGEs) in the shared biological mechanisms between type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD).", "results_summary": "The study found that AGEs, along with other mechanisms like insulin resistance and oxidative stress, contribute to the pathology of both T2DM and AD, suggesting a potential link between the two diseases. Understanding these shared mechanisms could lead to therapeutic interventions to delay AD onset or progression in T2DM patients.", "population_specificity": "Human clinical studies, animal models, and in vitro studies (not specified further).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:19.865941+00:00"}
{"study_id": 101766, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of the SphK1/S1P pathway, activated by Advanced Glycation End Products, in the pathogenesis of diabetic nephropathy and its potential as a therapeutic target.", "results_summary": "The study found that the SphK1/S1P pathway, activated by Advanced Glycation End Products, promotes glomerular mesangial cell proliferation and extracellular matrix accumulation, contributing to diabetic renal fibrosis. The pathway is closely linked to the progression of diabetic nephropathy, suggesting its potential as a therapeutic target.", "population_specificity": "Patients with diabetic nephropathy (not explicitly specified in the abstract).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:22.215652+00:00"}
{"study_id": 101768, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential role of the receptor for advanced glycation end products (RAGE) in spinal cord injury (SCI) and its implications for inflammation and axonal regeneration.", "results_summary": "The abstract highlights RAGE's association with inflammation and neurodegeneration, suggesting it as a potential therapeutic target for SCI, but does not present specific experimental results or outcomes.", "population_specificity": "Not specified (the abstract discusses SCI broadly without detailing a specific study population).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:23.584811+00:00"}
{"study_id": 101769, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 60, "study_goal": "The researchers examined the potential relevance of advanced glycation end products (AGEs) to mental health disorders, including depression and anxiety, in the context of modern dietary changes.", "results_summary": "The abstract suggests that dietary changes related to AGEs may be linked to mental health disorders, but it does not provide specific findings on their effects. The study highlights the need for further research to translate population studies into clinical and public health applications.", "population_specificity": "General population, with emphasis on prenatal and early childhood dietary practices.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:24.327903+00:00"}
{"study_id": 101767, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the associations between circulating S100A12 and sRAGE levels with clinical characteristics, inflammation, and mortality risk in CKD Stage 5 patients starting dialysis.", "results_summary": "The study found that S100A12 levels were significantly elevated in CKD patients and associated with inflammation, comorbidities, and increased mortality risk, while sRAGE levels were elevated but not linked to mortality or inflammation. The S100A12/sRAGE ratio was also markedly higher in CKD patients compared to controls.", "population_specificity": "Chronic kidney disease (CKD) Stage 5 patients starting dialysis, with comparative analyses in CKD Stages 3-4 patients, prevalent dialysis patients, and community-based controls.", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 23 months for mortality risk assessment.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:24.487660+00:00"}
{"study_id": 101770, "supplement_id": 857, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the role of advanced glycation end products (AGE) and their receptor RAGE in chronic kidney disease (CKD) progression and cardiovascular complications.", "results_summary": "The abstract summarizes current knowledge on AGE and RAGE's role in oxidative stress, inflammation, and kidney damage in diabetes and CKD, and discusses potential therapeutic avenues targeting the AGE-RAGE axis.", "population_specificity": "Patients with chronic kidney disease (CKD), including those with and without diabetes.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:25.393634+00:00"}
{"study_id": 104944, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Angelica keiskei Koidzumi (AKE) supplementation could improve liver function in habitual alcohol drinkers with abnormal liver biochemistry.", "results_summary": "AKE supplementation significantly reduced gamma-glutamyl transferase levels in heavy drinkers but did not significantly affect aspartate aminotransferase or alanine aminotransferase levels compared to placebo.", "population_specificity": "Habitual alcohol drinkers (male: >14 units/week, female: >7 units/week) with abnormal liver biochemistry, including heavy drinkers (>35 units/week).", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:33.231323+00:00"}
{"study_id": 104940, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the safety of intraperitoneal chemotherapy with raltitrexed during gastric cancer surgery compared to normal saline rinsing.", "results_summary": "The study found no significant differences in adverse effects, postoperative complications, or changes in blood markers (including alanine aminotransferase) between the raltitrexed and normal saline groups. All adverse events were mild or moderate.", "population_specificity": "91 gastric cancer patients undergoing surgery and reconstruction.", "effective_dosage": "Not specified for alanine.", "study_duration": "Single administration during surgery.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:33.348106+00:00"}
{"study_id": 104942, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify intrahepatic gene expression patterns associated with therapy response in peginterferon-treated chronic hepatitis B (CHB) patients, focusing on immune-related genes.", "results_summary": "The study found significant differences in 41 genes between responders and non-responders, with immune-related genes upregulated in responders. A 2-gene subset (HLA-DPB1, SERPIN-E1) accurately predicted treatment response.", "population_specificity": "40 CHB patients (19 HBeAg-positive; 21 HBeAg-negative).", "effective_dosage": "Not specified.", "study_duration": "48 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:33.454516+00:00"}
{"study_id": 104941, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to define anti-HBc levels in different phases of chronic hepatitis B (CHB) and correlate them with alanine aminotransferase (ALT) and other HBV-related markers.", "results_summary": "The study found significant differences in anti-HBc levels across different phases of CHB, with strong correlations in the immune clearance phase and poor or no correlations in other phases. These results may provide insights into hepatitis B pathogenesis and immune activation.", "population_specificity": "211 treatment-naive CHB patients classified into immune tolerance, immune clearance, low/no-replicative, and HBeAg-negative hepatitis phases, plus 50 past HBV infection controls.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:33.736556+00:00"}
{"study_id": 104946, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of lixisenatide on normalizing elevated liver blood tests, specifically alanine aminotransferase (ALT) and aspartate aminotransferase (AST), in patients with type 2 diabetes.", "results_summary": "Lixisenatide increased the proportion of patients achieving normal ALT levels, particularly in overweight or obese individuals, but had no effect on AST, alkaline phosphatase, or bilirubin. The effect on ALT was not confirmed in sequential analysis, suggesting the need for further research.", "population_specificity": "Patients with type 2 diabetes, specifically those who were overweight or obese.", "effective_dosage": "Not specified", "study_duration": "Mean treatment duration was 29 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:36.709174+00:00"}
{"study_id": 104943, "supplement_id": 863, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to assess the long-term efficacy, safety, and resistance of tenofovir disoproxil fumarate (TDF) in treating chronic hepatitis B (CHB) patients, including its impact on alanine aminotransferase normalization.", "results_summary": "The study found that 80.0% of patients achieved serum alanine aminotransferase normalization, with sustained viral suppression (99.3%) and no TDF resistance over 7 years. Safety profiles were favorable, with minimal renal and bone-related adverse events.", "population_specificity": "HBeAg-positive and HBeAg-negative chronic hepatitis B patients.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Up to 7 years (336 weeks).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:37.390156+00:00"}
{"study_id": 104945, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 15, "quality_score": 75, "study_goal": "The researchers evaluated the efficacy and safety of the PI3K inhibitor pilaralisib in patients with advanced or recurrent endometrial carcinoma, including monitoring for adverse events such as increased alanine aminotransferase levels.", "results_summary": "Pilaralisib showed minimal antitumor activity (ORR 6.0%) and a favorable safety profile, with increased alanine aminotransferase reported as a grade \u22653 adverse event in 4.5% of patients. No association was found between molecular alterations and clinical response.", "population_specificity": "Patients with histologically confirmed advanced or recurrent endometrial carcinoma who had received one or two prior chemotherapy regimens.", "effective_dosage": "600mg capsules or 400mg tablets once daily.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:38.192674+00:00"}
{"study_id": 104950, "supplement_id": 863, "safety_score": "75", "efficacy_score": null, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the safety and management of liver injury related to anti-TNF therapy, including the role of alanine aminotransferase abnormalities.", "results_summary": "The study found that hypertransaminasemia in IBD patients treated with anti-TNF agents is common but usually self-limiting, with a low risk of severe liver injury. Anti-TNF therapy was generally safe, and drug withdrawal was rarely necessary.", "population_specificity": "Patients with inflammatory bowel disease (IBD) treated with anti-TNF therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:41.265327+00:00"}
{"study_id": 104948, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether phlebotomy, which reduces ferritin levels, could improve liver enzymes (including alanine aminotransaminase [ALT]), hepatic fat, or insulin resistance in patients with nonalcoholic fatty liver disease (NAFLD).", "results_summary": "The study found no significant difference in ALT levels, hepatic steatosis, or insulin resistance between the phlebotomy and control groups, indicating that reducing ferritin via phlebotomy did not improve these outcomes in NAFLD patients.", "population_specificity": "Patients with nonalcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not applicable (phlebotomy intervention).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:41.584708+00:00"}
{"study_id": 104951, "supplement_id": 863, "safety_score": "90", "efficacy_score": 75, "quality_score": 80, "study_goal": "To assess the effect of vitamin E on alanine aminotransferase (ALT) levels in patients with HCV genotype 3 infection.", "results_summary": "Vitamin E treatment significantly reduced serum ALT levels in HCV genotype 3 patients compared to placebo, with 57.8% of the vitamin E group showing a response versus 29.4% in the placebo group. The treatment was well-tolerated with no serious adverse events reported.", "population_specificity": "Patients with HCV genotype 3 infection who could not receive, tolerate, or did not respond to standard therapy.", "effective_dosage": "400 IU twice daily", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:41.709441+00:00"}
{"study_id": 104949, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine how the Cx50 V44A mutation (involving alanine substitution) causes congenital cataracts by examining its effects on hemichannel and gap junction functionality.", "results_summary": "The study found that the Cx50 V44A mutation impairs hemichannel gating but not gap junction formation, leading to dysfunctional hemichannels and congenital cataracts. Both wild-type Cx50 and Cx50V44A formed functional gap junctions, but only the wild-type formed open hemichannels.", "population_specificity": "A Chinese family with autosomal dominant congenital nuclear cataracts.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:42.720919+00:00"}
{"study_id": 104947, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to summarize existing knowledge about predictors for methotrexate (MTX) efficacy and adverse events, including alanine aminotransferase levels, in juvenile idiopathic arthritis (JIA) patients.", "results_summary": "The study identified alanine aminotransferase levels as a potential predictor for MTX adverse events, but validation in independent cohorts was lacking.", "population_specificity": "Juvenile idiopathic arthritis (JIA) patients", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:43.154083+00:00"}
{"study_id": 104953, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety of biologic agents, including alanine aminotransferase elevations, in patients with juvenile idiopathic arthritis (JIA) and associated uveitis.", "results_summary": "The study found that alanine aminotransferase elevations were among the most common adverse events observed, but the abstract does not specify their severity or clinical impact. No direct conclusions about alanine's safety or efficacy were drawn.", "population_specificity": "Patients with juvenile idiopathic arthritis (JIA) and associated uveitis in Finland.", "effective_dosage": "Not specified for alanine.", "study_duration": "Median follow-up of 51 months (range 1-155).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:45.558323+00:00"}
{"study_id": 104952, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers examined the role of serum alanine aminotransferase levels in predicting spontaneous HBsAg seroconversion and HBV recovery in chronically infected patients.", "results_summary": "Elevated serum alanine aminotransferase levels (>30 IU/l) before age 48 months were a strong predictor of spontaneous HBsAg seroconversion (OR 17.7, p < 0.001). The study also linked IL-10 and IL-12 serum levels to HBV recovery.", "population_specificity": "296 chronically HBV-infected patients and 193 HBV recoverers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:46.633880+00:00"}
{"study_id": 104954, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether serum IFN-\u03bb(3) levels, influenced by clinical and immunological factors, are involved in the response to PEG-IFN-\u03b1 plus RBV therapy in chronic hepatitis C patients.", "results_summary": "Serum IFN-\u03bb(3) levels were elevated in chronic hepatitis C patients and correlated with liver disease activity and fibrosis, but were not associated with treatment response to PEG-IFN-\u03b1 plus RBV therapy.", "population_specificity": "119 chronic hepatitis C patients with HCV genotype 1 infection, 23 healthy subjects, and 56 patients with non-HCV viral hepatitis.", "effective_dosage": "Not specified", "study_duration": "48 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:46.711105+00:00"}
{"study_id": 104958, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers were investigating alternative vaccination strategies for dengue fever, not Alanine.", "results_summary": "The study compared different dengue vaccination regimens, noting immunogenicity and viraemia patterns, but did not evaluate Alanine.", "population_specificity": "150 healthy adults", "effective_dosage": "Not applicable", "study_duration": "Vaccinations administered on days 0 and 105 (\u00b115 days)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:49.688424+00:00"}
{"study_id": 104957, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine whether corn peptides (CPs), which contain alanine, could improve lipid profile, oxidative stress, and liver injury in men with chronic alcohol consumption.", "results_summary": "CPs supplementation significantly improved lipid metabolism, reduced oxidative stress markers, and lowered liver injury indicators compared to whey protein and placebo. It also increased antioxidant enzyme activities, suggesting protective effects against alcohol-induced liver damage.", "population_specificity": "161 men with chronic alcohol consumption (146 completed the study).", "effective_dosage": "4 g/day (2 g twice daily).", "study_duration": "9 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:50.183174+00:00"}
{"study_id": 104956, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were evaluating the safety, antitumor activity, and pharmacokinetics of buparlisib and trametinib in patients with RAS- or BRAF-mutant cancers, not specifically studying Alanine.", "results_summary": "The study found increased AST/ALT (including alanine aminotransferase) levels as treatment-related adverse events, but Alanine itself was not the focus of the research. Minimal antitumor activity was observed in non-small cell lung and pancreatic cancers, with better responses in ovarian cancer.", "population_specificity": "Patients with RAS- or BRAF-mutant non-small cell lung, ovarian, or pancreatic cancer.", "effective_dosage": "Not applicable (Alanine not studied as an intervention).", "study_duration": "Not specified for Alanine.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:50.792218+00:00"}
{"study_id": 104959, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to examine the efficacy of ezetimibe versus placebo in reducing liver fat and improving liver histology in patients with biopsy-proven NASH.", "results_summary": "Ezetimibe did not significantly reduce liver fat compared to placebo, though it showed a modest reduction from baseline. No significant differences were observed in histologic response rates or liver enzyme levels between the groups.", "population_specificity": "Patients with biopsy-proven nonalcoholic steatohepatitis (NASH).", "effective_dosage": "10 mg orally daily", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:50.820274+00:00"}
{"study_id": 104960, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not evaluate Alanine; it focuses on acetaminophen's effects on oxidative injury and renal function in severe sepsis patients.", "results_summary": "The study does not report findings related to Alanine.", "population_specificity": "Critically ill adults with severe sepsis and detectable plasma cell-free hemoglobin.", "effective_dosage": "Not applicable", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:52.031635+00:00"}
{"study_id": 104955, "supplement_id": 863, "safety_score": "65", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy and safety of obeticholic acid (OCA) in reducing alkaline phosphatase (ALP) and other liver enzymes, including alanine aminotransferase, in patients with primary biliary cirrhosis who had an inadequate response to ursodeoxycholic acid therapy.", "results_summary": "OCA significantly reduced ALP, \u03b3-glutamyl transpeptidase, and alanine aminotransferase levels compared to placebo, with the most common adverse event being pruritus, which varied in incidence by dosage. Biochemical improvements were maintained in a 12-month extension trial.", "population_specificity": "Patients with primary biliary cirrhosis (95% women) and elevated ALP levels (1.5- to 10-fold the upper limit of normal).", "effective_dosage": "10 mg, 25 mg, or 50 mg OCA once daily.", "study_duration": "3 months (with a 12-month open-label extension for some participants).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:53.227470+00:00"}
{"study_id": 104962, "supplement_id": 863, "safety_score": "70", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the efficacy of obeticholic acid (not Alanine) in improving liver histology in adult patients with non-alcoholic steatohepatitis.", "results_summary": "Obeticholic acid significantly improved liver histology in 45% of patients compared to 21% in the placebo group, but pruritus was more common in the treatment group (23% vs. 6%).", "population_specificity": "Adult patients with non-cirrhotic, non-alcoholic steatohepatitis.", "effective_dosage": "25 mg daily", "study_duration": "72 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:54.858029+00:00"}
{"study_id": 104961, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 30, "study_goal": "The researchers were examining a case of azathioprine-induced hepatotoxicity, not specifically evaluating Alanine.", "results_summary": "The study reported elevated alanine aminotransferase (ALT) levels as part of liver injury due to azathioprine toxicity, but did not assess Alanine's effects.", "population_specificity": "A 47-year-old man with myasthenia gravis on azathioprine therapy.", "effective_dosage": "Not mentioned (azathioprine dosage not specified).", "study_duration": "1 year of azathioprine use prior to hepatotoxicity.", "interactions": "None mentioned (related to Alanine).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:54.985809+00:00"}
{"study_id": 104964, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and efficacy of ganetespib, an Hsp90 inhibitor, in patients with refractory metastatic colorectal cancer, not specifically Alanine.", "results_summary": "The study found no objective regression of disease in patients treated with ganetespib, though two patients had stable disease for 5.1 and 6.8 months. Adverse events included diarrhea, fatigue, and increased liver enzyme levels.", "population_specificity": "Patients with chemotherapy-refractory, metastatic colorectal cancer (median age 58, range 44-79 years).", "effective_dosage": "200 mg/m\u00b2 intravenously.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:58.416281+00:00"}
{"study_id": 104965, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify unique metabolic pathways in MRSA, including those involving Alanine, to discover potential drug targets.", "results_summary": "The study identified Glutamate synthase, involved in Alanine metabolism, as a promising drug target due to its absence in humans and essential role in MRSA. The 3D structure of this enzyme was modeled and validated for potential drug development.", "population_specificity": "In silico analysis of MRSA strain 252 (MRSA252) and human metabolic pathways.", "effective_dosage": "Not available", "study_duration": "Not applicable (computational study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:39:59.793532+00:00"}
{"study_id": 104966, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to compare the antiviral efficacy of different nucleos(t)ide analogues (including lamivudine, entecavir, telbivudine, and a lamivudine-adefovir combination) in untreated hepatitis B patients, with a focus on serum alanine transaminase (ALT) levels and HBV DNA reduction.", "results_summary": "The study found no significant differences in effectiveness among the tested nucleos(t)ide analogues over a 52-week period, with high HBV DNA undetectability rates (83-96%) and ALT normalization rates (65-83%) depending on early treatment response. Patients with undetectable HBV DNA at week 24 had better outcomes at week 52.", "population_specificity": "Chinese nucleos(t)ide-naive hepatitis B patients (n=164).", "effective_dosage": "Not specified in the abstract.", "study_duration": "52 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:02.011700+00:00"}
{"study_id": 104967, "supplement_id": 863, "safety_score": "23", "efficacy_score": 57, "quality_score": 75, "study_goal": "The researchers evaluated the efficacy and safety of hepatic arterial infusion chemotherapy (HAIC) using fine-powder cisplatin and iodized-oil suspension in patients with intermediate- and advanced-stage hepatocellular carcinomas (HCCs), including the impact on serum alanine levels.", "results_summary": "The study found that 23% of patients experienced grade-3 or grade-4 elevation of serum alanine aminotransferase, indicating significant adverse effects. The treatment showed modest therapeutic effects, with response rates varying based on RECIST and mRECIST criteria.", "population_specificity": "Patients with intermediate- and advanced-stage HCCs (BCLC stage-B and stage-C), not candidates for other locoregional treatments (mean age 74 \u00b1 6 years).", "effective_dosage": "Maximum dose of 65 mg/m\u00b2 fine-powder cisplatin with iodized oil on demand.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:02.371721+00:00"}
{"study_id": 104969, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the clinical usefulness of non-invasive fibrosis indices, including AST/alanine aminotransferase, in predicting hepatocellular carcinoma (HCC) among Egyptian patients.", "results_summary": "The study found that combining alpha-fetoprotein and FIB4 Score showed high diagnostic performance for HCC (93% sensitivity, 96% specificity), while APRI Score effectively differentiated cirrhosis from controls (100% sensitivity and specificity). Alanine-related indices were part of the broader assessment but were not individually highlighted in the results.", "population_specificity": "Egyptian patients (90 with HCC, 30 with cirrhosis, 30 healthy controls).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:03.800841+00:00"}
{"study_id": 104968, "supplement_id": 863, "safety_score": "70", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to determine the safety, pharmacokinetics, and toxicities of enzastaurin, including its effects on alanine transaminase levels, in children with recurrent CNS malignancies.", "results_summary": "The study found that enzastaurin was generally well-tolerated, with grade 3 alanine transaminase elevation reported in one participant at the highest dose. No objective responses were observed, but stable disease was noted in some participants.", "population_specificity": "Children with recurrent central nervous system malignancies.", "effective_dosage": "260, 340, and 440 mg/m\u00b2 once daily; 440 mg/m\u00b2 twice daily.", "study_duration": "Continuous daily administration (specific duration not detailed in abstract).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:04.018046+00:00"}
{"study_id": 104970, "supplement_id": 863, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the durability of transgene expression, dose-response relationship, and long-term safety of AAV8 vector-mediated gene therapy in patients with severe hemophilia B, including monitoring alanine aminotransferase levels.", "results_summary": "A transient increase in alanine aminotransferase levels occurred in 4 of 6 high-dose patients, resolving after prednisolone treatment. No late toxic effects were reported over a median follow-up of 3.2 years.", "population_specificity": "10 patients with severe hemophilia B.", "effective_dosage": "2\u00d710^12 vector genomes per kilogram of body weight (high dose).", "study_duration": "Single infusion with follow-up for up to 3 years.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:04.307400+00:00"}
{"study_id": 104971, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the effectiveness and safety of low-dose prednisone or cyclosporine A combined with nucleoside analogs in patients with severe thrombocytopenia associated with HBV-related liver cirrhosis.", "results_summary": "The study found that low-dose prednisone or cyclosporine A combined with nucleoside analogs elevated platelet counts and reduced bleeding events compared to nucleoside analogs alone, with no significant differences in HBV-DNA or alanine transaminase rates among groups. Adverse events were mild and balanced across treatment groups.", "population_specificity": "145 compensated HBV-associated liver cirrhosis patients with severe thrombocytopenia.", "effective_dosage": "Not specified (low-dose prednisone or cyclosporine A).", "study_duration": "From 1 January 2006 to 31 December 2013 (exact intervention duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:07.268665+00:00"}
{"study_id": 104972, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to assess the risk and incidence of hepatotoxicity in HIV patients coinfected with HCV after initiating HAART, not specifically about Alanine.", "results_summary": "Coinfected patients had higher transaminase levels (AST and ALT) and a 3.7 times higher risk of hepatotoxicity after HAART initiation compared to monoinfected patients, though no severe hepatotoxicity occurred.", "population_specificity": "HIV patients (30 coinfected with HCV, 35 monoinfected).", "effective_dosage": "Not mentioned", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:07.345346+00:00"}
{"study_id": 104963, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a diet high in total antioxidant capacity, including co-supplemented hemp seed and evening primrose oils with a Hot-nature diet, could improve liver enzyme activity (ALT, AST, GGT) and EDSS scores in MS patients.", "results_summary": "The intervention led to significant decreases in EDSS scores and liver enzyme levels in groups receiving co-supplemented oils (groups A and C), while group B (olive oil) showed elevated liver enzymes and EDSS scores. The results suggest that antioxidant-rich diets may benefit liver function and disease progression in MS patients.", "population_specificity": "65 MS patients (23 male, 42 female) aged 34.25\u00b18.07 years with disease duration of 6.80\u00b14.33 years and EDSS<6.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:09.658846+00:00"}
{"study_id": 104974, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the hepatocellular carcinoma (HCC) risk and the predictive role of alanine aminotransferase (ALT) levels and other factors in patients with chronic HBV infection treated with entecavir.", "results_summary": "The study found that ALT level normalization occurred in 62% of patients at 24 weeks and 72% at 1 year, but HCC incidence was not affected by ALT normalization. Advanced age, cirrhosis, and higher AFP levels at 24 weeks were independent risk factors for HCC.", "population_specificity": "496 Japanese patients with chronic HBV infection (mean age 52.6 years, 58% male, 19% with cirrhosis).", "effective_dosage": "Not specified", "study_duration": "Mean treatment duration was 49.9 \u00b1 17.5 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:12.065676+00:00"}
{"study_id": 104973, "supplement_id": 863, "safety_score": "65", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the efficacy and safety of oral decernotinib (VX-509) monotherapy in patients with rheumatoid arthritis (RA).", "results_summary": "Decernotinib showed significant efficacy in improving RA symptoms at dosages of 50-150 mg twice daily, with higher ACR20, ACR50, and ACR70 response rates compared to placebo. Adverse events included nausea, headache, increased alanine aminotransferase levels, and hypercholesterolemia, with infections and elevated liver transaminases noted as potential safety concerns.", "population_specificity": "Adults with active RA who had previously failed treatment with \u22651 disease-modifying antirheumatic drug.", "effective_dosage": "25 mg, 50 mg, 100 mg, or 150 mg twice daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:12.135038+00:00"}
{"study_id": 104976, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-inflammatory and hepatoprotective effects of Astragalus gummifer extracts (AGHE and AGRE) in Wistar rats, with a focus on markers like alanine aminotransferase (ALT).", "results_summary": "Both AGHE and AGRE showed significant anti-inflammatory activity (P<0.001). AGRE demonstrated stronger hepatoprotective effects (P<0.001) than AGHE (P<0.05), evidenced by reduced serum levels of ALT, AST, GGT, ALP, and total bilirubin.", "population_specificity": "Wistar rats", "effective_dosage": "250 and 500 mg/kg body weight", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:12.585568+00:00"}
{"study_id": 104977, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers investigated the association between elevated alanine transaminase (ALT) levels and impaired glucose tolerance (IGT) in individuals with hepatitis B virus (HBV) infection.", "results_summary": "Elevated ALT levels were associated with an increased risk of IGT (OR = 1.10). The study also found that lower educational attainment, male gender, older age, and elevated triglycerides were linked to higher IGT prevalence.", "population_specificity": "Individuals with HBV infection from the Korean National Health and Nutrition Examination Survey (2007-2011).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:13.487705+00:00"}
{"study_id": 104975, "supplement_id": 863, "safety_score": "70", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and efficacy of combined oral deferiprone (DFP) and subcutaneous desferrioxamine (DFO) therapy in reducing ferritin levels in transfusion-dependent \u03b2-thalassemia children.", "results_summary": "The combination therapy significantly reduced median ferritin levels from 2,954.6 to 936.6 ng/ml in responders, with adverse events including elevated alanine aminotransferase (n = 5) and other minor side effects. Nonresponders had higher median age and longer transfusion duration.", "population_specificity": "Transfusion-dependent \u03b2-thalassemia children (ages 3-18 years), including \u03b2-thalassemia major and \u03b2-thalassemia hemoglobin E patients.", "effective_dosage": "50-100 mg/kg/day oral DFP combined with 40 mg/kg/dose s.c. DFO twice weekly.", "study_duration": "Up to 36 months (28 patients completed follow-up).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:14.312810+00:00"}
{"study_id": 104979, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate nonspecific adverse events (AEs) in placebo groups, including elevated alanine aminotransferase, to better understand their impact on clinical trials.", "results_summary": "The study found elevated alanine aminotransferase as the most common objective AE in placebo groups (0.59%), but did not assess alanine's efficacy or safety directly. Nonspecific AEs in placebo groups accounted for a significant portion of AEs in active treatment groups.", "population_specificity": "Patients in randomized, placebo-controlled knee osteoarthritis clinical trials.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:16.137400+00:00"}
{"study_id": 104978, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to assess whether the combination of prednisolone, UDCA, and azathioprine was superior to UDCA alone in treating pure primary biliary cirrhosis (PBC) patients with high IgG and transaminase levels.", "results_summary": "The combination therapy showed significant improvements in liver function markers (ALP, IgG, ALB, APRI, S-index) compared to UDCA alone, with minimal or absent side effects.", "population_specificity": "Pure PBC patients with high IgG and transaminase levels, excluding PBC-autoimmune hepatitis overlap syndrome.", "effective_dosage": "Not specified for alanine (study focused on prednisolone, UDCA, and azathioprine).", "study_duration": "3 years", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:16.900398+00:00"}
{"study_id": 104980, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers were evaluating the efficacy and toxicity of thalidomide combined with TACE in patients with advanced hepatocellular carcinoma (HCC), not specifically studying alanine.", "results_summary": "Elevated alanine aminotransferase (38.2%) was noted as a grade 3-4 toxicity, but the study did not focus on alanine's effects.", "population_specificity": "Patients with unresectable HCC amenable to TACE (n=56).", "effective_dosage": "Not applicable (alanine was not a studied intervention).", "study_duration": "Not applicable (alanine was not a studied intervention).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:18.815170+00:00"}
{"study_id": 104982, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to identify predictors of mortality in Indian patients with leptospirosis, including the role of the aspartate/alanine aminotransferase ratio (AAR).", "results_summary": "The study found that a high AAR and delayed antibiotic therapy were significant predictors of mortality in leptospirosis patients. Alanine itself was not directly evaluated for efficacy or safety.", "population_specificity": "Indian patients diagnosed with leptospirosis (n=101).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:19.171276+00:00"}
{"study_id": 104981, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the systemic metabolic effects of psoriasis, including perturbations in alanine metabolism, and assess the impact of anti-TNF\u03b1 treatment (Etanercept) on these metabolic pathways.", "results_summary": "The study identified significant perturbations in the alanine, aspartate, and glutamate metabolic pathways in psoriasis patients, which were reversed by Etanercept treatment. Circulating alanine levels correlated with disease severity and therapeutic response, suggesting its potential as a biomarker.", "population_specificity": "Individuals with mild or severe psoriasis and healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:19.848131+00:00"}
{"study_id": 104984, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to develop and implement a program (eDISH) to assess drug-induced liver injury (DILI) using alanine aminotransferase (ALT) and total bilirubin (TBL) values in clinical trial subjects.", "results_summary": "The study introduced the eDISH program to monitor liver injury in clinical trials, which has contributed to improved awareness and reduced post-marketing hepatotoxicity withdrawals since 1997. The abstract does not provide specific results about Alanine's effects.", "population_specificity": "Subjects enrolled in clinical trials for drug safety assessment.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:21.636006+00:00"}
{"study_id": 104983, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to discuss challenges in assessing drug-induced liver injury (DILI) in populations with underlying liver disease and the need for clearer guidelines on stopping rules based on serum alanine aminotransferase (ALT) levels.", "results_summary": "The abstract highlights the lack of consensus in defining stopping rules for DILI based on ALT levels and emphasizes the need for precompetitive data sharing to improve understanding and evidence-based guidelines. It also notes the challenges in liver safety assessment for populations with underlying liver disease.", "population_specificity": "Populations with underlying liver disease (e.g., viral hepatitis or metastatic cancer).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:21.807101+00:00"}
{"study_id": 104985, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy of lamivudine monotherapy, lamivudine plus adefovir dipivoxil combination therapy, and a lamivudine optimization strategy in treating HBeAg-positive chronic hepatitis B patients.", "results_summary": "Combination therapy and the optimization strategy showed better viral suppression (53.3% and 48.3% achieving HBV-DNA < 300 copies/mL) and lower resistance rates (0.8% and 6.7%) compared to monotherapy (34.8% suppression, 58.5% resistance). Early virological responders to monotherapy had superior outcomes (73.1% suppression, 40.4% seroconversion).", "population_specificity": "Adult HBeAg-positive chronic hepatitis B patients with HBV-DNA \u2265 10^5 copies/mL and compensated liver disease.", "effective_dosage": "Lamivudine 100 mg q.d., ADV 10 mg q.d.", "study_duration": "104 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:24.488570+00:00"}
{"study_id": 104987, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to compare the performance of BD Vacutainer\u00ae RST and SST tubes for measuring routine biochemistry parameters, including alanine aminotransferase (ALT).", "results_summary": "The study found that ALT results from RST tubes were comparable to those from SST tubes, with no clinically significant differences reported. Analyte stability studies showed ALT was stable for 24 hours at 4\u00b0C.", "population_specificity": "90 participants (specific demographics not detailed).", "effective_dosage": "Not applicable (study focused on sample collection methods).", "study_duration": "Not applicable (single time-point measurement).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:24.963011+00:00"}
{"study_id": 104986, "supplement_id": 863, "safety_score": "80", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to examine the safety and potential efficacy of short-term octreotide-LAR administration in reducing total kidney and liver volume increases in ADPKD patients.", "results_summary": "The study found a significant decrease in alanine aminotransferase but no significant changes in TKV, TLV, or eGFR. Adverse events were mild and resolved spontaneously.", "population_specificity": "Four ADPKD patients with eGFR > 45 mL/min/1.73 m\u00b2, TKV > 1,000 mL, and TLV > 3,000 mL.", "effective_dosage": "Two 20-mg octreotide-LAR intramuscular injections every 4 weeks.", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:25.789269+00:00"}
{"study_id": 104989, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to compare plasma and salivary levels of biochemical parameters, including alanine transaminase (ALT), between healthy individuals and patients with chronic periodontitis (CP).", "results_summary": "The study found only a slight increase in plasma ALT levels in patients with CP compared to healthy individuals (12.35 vs. 15.95 IU/L), but salivary ALT levels showed a \u22486-fold rise in CP patients. Cross-correlation analysis linked plasma and salivary AST/ALT with uric acid levels in CP patients.", "population_specificity": "40 patients with chronic periodontitis and 20 healthy individuals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:27.166746+00:00"}
{"study_id": 104988, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the antiviral effects of peg-IFN-\u03b12a and peg-IFN-\u03b12b in chronic hepatitis C patients, including their impact on viraemia decline and viral load rebound.", "results_summary": "Peg-IFN-\u03b12b showed a significantly greater early viraemia decline compared to peg-IFN-\u03b12a, particularly in patients with advanced fibrosis, genotype 1 infection, and specific IL28B genotypes. However, viral load rebound was more frequent with peg-IFN-\u03b12b, and differences between the two peg-IFNs disappeared by day 28 of treatment.", "population_specificity": "Chronic hepatitis C patients treated with ribavirin combined with peg-IFN-\u03b12a (N = 109) or peg-IFN-\u03b12b (N = 114).", "effective_dosage": "Not specified", "study_duration": "90 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:28.535234+00:00"}
{"study_id": 104990, "supplement_id": 863, "safety_score": "75", "efficacy_score": 50, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety, feasibility, and tolerability of intravenous dantrolene (IV-D) in patients with aneurysmal subarachnoid hemorrhage (aSAH), including its effects on liver toxicity (alanine transaminase levels) and other adverse events.", "results_summary": "The study found no significant differences in primary safety outcomes (hyponatremia or liver toxicity) between IV-D and placebo groups. Adverse events were mostly unrelated to infusion, and no efficacy differences were observed in cerebral vasospasm, delayed cerebral ischemia, or functional outcomes.", "population_specificity": "Patients with aneurysmal subarachnoid hemorrhage (aSAH).", "effective_dosage": "1.25 mg every 6 hours for 7 days.", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:28.729689+00:00"}
{"study_id": 104991, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the association between PCOS and NAFLD, including potential screening methods involving alanine aminotransferase.", "results_summary": "The study highlights the link between PCOS and NAFLD, suggesting screening for NAFLD in high-risk PCOS patients using alanine aminotransferase or ultrasound, with lifestyle interventions as first-line treatment.", "population_specificity": "Reproductive-aged women with PCOS and metabolic risk factors.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:28.848164+00:00"}
{"study_id": 104992, "supplement_id": 863, "safety_score": "65", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the maximum tolerated dose, toxicity, and pharmacokinetics of trastuzumab emtansine (T-DM1) in Japanese breast cancer patients, including its effects on alanine aminotransferase levels.", "results_summary": "The study found that T-DM1 was generally well tolerated, with dose-limiting toxicity observed as Grade 3 elevation of alanine aminotransferase at 2.4 mg/kg. The maximum tolerated dose was estimated to be 3.6 mg/kg, and adverse events were manageable.", "population_specificity": "Japanese patients with inoperable advanced or recurrent human epidermal growth factor receptor 2-positive breast cancer.", "effective_dosage": "1.8, 2.4, or 3.6 mg/kg every 3 weeks.", "study_duration": "Median of seven cycles (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:31.400024+00:00"}
{"study_id": 104993, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify risk factors, including high serum alanine aminotransferase (ALT) levels, associated with hepatocellular carcinoma (HCC) progression in Asian HBV carriers.", "results_summary": "High serum ALT levels were independently associated with increased HCC risk in Asian HBV carriers, alongside other factors like HBV-DNA levels and HBsAg levels. The study developed risk stratification tools combining these markers for better disease progression prediction.", "population_specificity": "Asian adults with chronic HBV infection.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:31.783640+00:00"}
{"study_id": 104994, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether aerobic exercise training could improve liver enzyme levels (including Alanine Aminotransferase, ALT) and psychological well-being in patients with chronic hepatitis C.", "results_summary": "The study found a significant decrease in ALT levels and improvements in psychological well-being in the group receiving aerobic exercise training, with no significant changes in the control group.", "population_specificity": "Fifty patients with chronic hepatitis C, divided into two equal groups.", "effective_dosage": "Not specified (intervention was aerobic exercise training, not direct Alanine supplementation).", "study_duration": "Three months (three sessions per week).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:32.619212+00:00"}
{"study_id": 104996, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers sought to identify predictors of response to telaprevir-based triple therapy, including the role of baseline alanine aminotransferase levels.", "results_summary": "Higher baseline alanine aminotransferase levels were associated with lower odds of sustained viral response (OR = 0.62; 95% CI, 0.40-0.97), indicating a negative predictive relationship. The study did not evaluate alanine as a therapeutic agent but as a biomarker.", "population_specificity": "Patients with prior treatment response to peginterferon plus ribavirin (n = 465), including relapsers, partial responders, and null-responders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:36.367326+00:00"}
{"study_id": 104995, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the efficacy and safety of bone marrow-derived mesenchymal stem cells (BM-MSC) in treating decompensated liver cirrhosis, including effects on liver function markers such as alanine aminotransferase.", "results_summary": "BM-MSC infusion improved liver function markers, including alanine aminotransferase, MELD scores, albumin levels, and prothrombin times, with no serious adverse events reported. The improvements were observed over 24 to 48 weeks post-transfusion.", "population_specificity": "Patients with decompensated liver cirrhosis from studies conducted in China, Iran, Egypt, and Brazil.", "effective_dosage": "Not specified", "study_duration": "Follow-up periods ranged from 2 to 48 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:36.614143+00:00"}
{"study_id": 104998, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether resveratrol supplementation, combined with lifestyle modifications, improves outcomes in NAFLD patients compared to lifestyle modifications alone.", "results_summary": "Resveratrol supplementation significantly reduced liver enzyme alanine aminotransferase, inflammatory cytokines, hepatic steatosis grade, and other markers compared to placebo, indicating superior efficacy in managing NAFLD when combined with lifestyle changes.", "population_specificity": "50 NAFLD patients", "effective_dosage": "500 mg resveratrol capsule daily", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:37.854123+00:00"}
{"study_id": 104999, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of probiotic yogurt consumption on metabolic factors, including alanine aminotransferase levels, in patients with nonalcoholic fatty liver disease (NAFLD).", "results_summary": "Probiotic yogurt consumption reduced serum alanine aminotransferase levels by 4.67% compared to the control group, alongside improvements in other hepatic enzymes and lipid profiles. No significant changes were observed in serum glucose, triglycerides, or high-density lipoprotein cholesterol levels.", "population_specificity": "72 NAFLD patients (33 males, 39 females) aged 23-63 years.", "effective_dosage": "300 g/day of probiotic yogurt containing Lactobacillus acidophilus La5 and Bifidobacterium lactis Bb12.", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:38.143074+00:00"}
{"study_id": 105001, "supplement_id": 863, "safety_score": "75", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of SAR245409 (voxtalisib) in patients with relapsed/refractory lymphoma, including its impact on alanine aminotransferase levels.", "results_summary": "The study found that SAR245409 was associated with treatment-related adverse events, including increased alanine aminotransferase (12.5% grade 3/4). Preliminary efficacy showed one complete response and two partial responses among evaluable patients, with evidence of PI3K/mTOR pathway inhibition.", "population_specificity": "16 patients with relapsed/refractory lymphoma.", "effective_dosage": "50 mg twice daily.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:40.697357+00:00"}
{"study_id": 105000, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to describe the autoimmune features and outcomes of children with autoimmune fulminant hepatic failure (AI-FHF) and indeterminate FHF (ID-FHF), including the role of immunosuppressive drugs.", "results_summary": "The study found that AIH is a more common cause of FHF than previously thought, with distinct autoimmune features in AI-FHF compared to ID-FHF. A cautious steroid trial allowed some AI-FHF patients to recover without liver transplantation.", "population_specificity": "Children with fulminant hepatic failure (46 patients, including 10 with AI-FHF and 20 with ID-FHF).", "effective_dosage": "Not specified", "study_duration": "Mean follow-up time was 4.6 years.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:41.572488+00:00"}
{"study_id": 105002, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine the benefits and harms of androgens (including oxymetholone and nandrolone decanoate) for treating anaemia in adults with chronic kidney disease (CKD).", "results_summary": "Limited evidence suggests oxymetholone and nandrolone decanoate may improve haemoglobin and haematocrit levels in CKD patients, but no significant benefits were found for other markers like BUN, creatinine, or lipids. Adverse events were infrequently reported, but the evidence was insufficient to confirm overall benefits.", "population_specificity": "Adults with chronic kidney disease (CKD)-related anaemia.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:42.055658+00:00"}
{"study_id": 104997, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the molecular mechanisms of FK506-induced hypertension in solid organ transplantation subjects, including the role of the WNKs/SPAK/NCC pathway where alanine-rich kinase is involved.", "results_summary": "The study identified that the WNKs/SPAK/NCC pathway, which includes alanine-rich kinase, plays a central role in tacrolimus-induced hypertension, contributing to endothelial dysfunction and inflammation.", "population_specificity": "Solid organ transplantation patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:45.033157+00:00"}
{"study_id": 105004, "supplement_id": 863, "safety_score": "70", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to assess the cognitive effects of idalopirdine, a 5-HT6 receptor antagonist, in donepezil-treated patients with moderate Alzheimer's disease.", "results_summary": "Idalopirdine significantly improved cognitive function compared to placebo, with a treatment difference of -2.16 points on the ADAS-cog scale. Adverse events included transient increases in transaminase concentrations and other mild side effects, but serious adverse events were balanced between groups.", "population_specificity": "Patients aged 50+ with moderate Alzheimer's disease (MMSE score 12-19) stably treated with donepezil.", "effective_dosage": "90 mg per day (30 mg thrice daily).", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:47.297960+00:00"}
{"study_id": 105005, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy and safety of entecavir and tenofovir in treating chronic hepatitis B virus (HBV) patients, including their effects on alanine aminotransferase normalization.", "results_summary": "The study found no significant difference in alanine aminotransferase normalization rates between entecavir and tenofovir at 24 or 48 weeks. Tenofovir showed superior virological response compared to entecavir, particularly in nucleos(t)ide-na\u00efve patients at 48 weeks.", "population_specificity": "Chronic HBV patients, including nucleos(t)ide-na\u00efve individuals.", "effective_dosage": "Not specified", "study_duration": "24 and 48 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:48.856978+00:00"}
{"study_id": 105006, "supplement_id": 863, "safety_score": "65", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and efficacy of bosutinib plus capecitabine, including monitoring adverse events such as increased alanine aminotransferase levels.", "results_summary": "The study found that increased alanine aminotransferase was a frequent grade 3/4 adverse event, but no dose-limiting toxicities were observed at the maximum tolerated dose. Limited efficacy was observed, with only 6% of patients showing a partial response.", "population_specificity": "Patients with locally advanced/metastatic breast, pancreatic, or colorectal cancers; cholangiocarcinoma; or glioblastoma.", "effective_dosage": "Bosutinib 300 mg once daily plus capecitabine 1000 mg/m\u00b2 twice daily.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:49.268240+00:00"}
{"study_id": 105003, "supplement_id": 863, "safety_score": "64", "efficacy_score": 74, "quality_score": 82, "study_goal": "The researchers aimed to evaluate the safety, tolerability, and maximum tolerated dose of nintedanib combined with docetaxel in Japanese patients with advanced non-small-cell lung cancer, including monitoring alanine aminotransferase elevations as an adverse event.", "results_summary": "The study found that alanine aminotransferase elevations occurred in 64% of patients but were reversible and manageable with dose adjustments. The combination therapy showed promising efficacy, with 26% of evaluable patients achieving partial response and 47% achieving stable disease.", "population_specificity": "Japanese patients with advanced non-small-cell lung cancer, stratified by body surface area (BSA <1.5 m\u00b2 and BSA \u22651.5 m\u00b2).", "effective_dosage": "Nintedanib 100, 150, or 200 mg twice daily (days 2-21) combined with docetaxel 60 or 75 mg/m\u00b2 (day 1) in 21-day cycles.", "study_duration": "Treatment administered in 21-day cycles until dose-limiting toxicity or disease progression.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:50.338742+00:00"}
{"study_id": 105008, "supplement_id": 863, "safety_score": "65", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to determine the safety, maximum tolerated dose, and pharmacodynamic effects of golvatinib, an inhibitor targeting c-Met and other receptors, in patients with advanced solid tumors.", "results_summary": "The study found that golvatinib was well tolerated at 400 mg once daily, with common adverse events including diarrhea, nausea, and elevated alanine aminotransferase. Best overall response was stable disease, with pharmacodynamic evidence of c-Met target modulation.", "population_specificity": "Patients with advanced solid tumors.", "effective_dosage": "100 mg to 400 mg once daily.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:52.789893+00:00"}
{"study_id": 105009, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine if baseline serum \u03b1-amylase concentration, which includes alanine aminotransferase, could predict distance running performance in recreational runners.", "results_summary": "The study found that baseline serum \u03b1-amylase (including alanine aminotransferase) was a significant independent predictor of running performance, correlating with glucose variation and blood lactate levels post-run.", "population_specificity": "Forty-three amateur recreational runners completing a 21.1 km half-marathon.", "effective_dosage": "Not specified", "study_duration": "Single trial (21.1 km run)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:53.199629+00:00"}
{"study_id": 105007, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy and safety of tenofovir (TDF) and entecavir (ETV) therapy in chronic hepatitis B (CHB) patients, including their effects on alanine aminotransferase (ALT) normalization.", "results_summary": "The study found similar ALT normalization rates and times between TDF and ETV groups, with no significant differences. However, TDF showed a greater decline in HBV-DNA levels at 12 and 18 months, while ETV had a higher virological breakthrough rate (7%).", "population_specificity": "Treatment-na\u00efve patients with chronic hepatitis B (CHB), predominantly male (72%), mean age 43\u00b112 years.", "effective_dosage": "Not specified", "study_duration": "Mean treatment duration was 30.2\u00b115.7 months.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:54.618173+00:00"}
{"study_id": 105010, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to analyze the prevalence and distribution of KRAS mutations, including Glycine to Alanine mutations, in colorectal cancer patients to inform targeted therapy decisions.", "results_summary": "The study found that Glycine to Alanine mutations were relatively more prevalent in sigmoid, rectum, and rectosigmoid tumors, with KRAS mutations overall present in 42.8% of the study group.", "population_specificity": "299 unselected incidental colorectal cancer patients in India (2009-2013).", "effective_dosage": "Not available", "study_duration": "Not applicable (retrospective study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:54.765672+00:00"}
{"study_id": 105011, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the minimum weight reduction required for improvement of obesity-related risk factors, including alanine aminotransferase (ALT) levels, in obese and overweight Japanese individuals.", "results_summary": "The study found that weight reduction of \u22653% significantly improved ALT levels, along with other obesity-related parameters. Greater weight reduction (3% to <5% and \u22655%) led to improvements in all 11 measured parameters, including ALT.", "population_specificity": "Obese and overweight Japanese adults (n=3480; mean age 48.3\u00b15.9 years; mean BMI 27.7\u00b12.5 kg/m\u00b2) with \"Obesity Disease\" or \"Metabolic Syndrome.\"", "effective_dosage": "Not specified (lifestyle modification program).", "study_duration": "6-month intervention with 6-month follow-up (total 1 year).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:56.616835+00:00"}
{"study_id": 105012, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The study aimed to differentiate between intrahepatic biliary cystadenoma and cystadenocarcinoma using preoperative data, including serum assay results such as alanine aminotransferase.", "results_summary": "The study found no statistically significant differences in pre- or post-operative levels of alanine aminotransferase between cystadenoma and cystadenocarcinoma groups. Elevated bilirubin levels were observed in some patients in both groups.", "population_specificity": "Patients diagnosed with intrahepatic biliary cystadenoma (21 cases) or cystadenocarcinoma (25 cases) at the General Hospital of PLA between 2003 and 2013.", "effective_dosage": "Not available", "study_duration": "Not applicable (retrospective analysis)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:57.408142+00:00"}
{"study_id": 105013, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 95, "study_goal": "The researchers aimed to evaluate the efficacy and safety of tenofovir disoproxil fumarate (TDF) compared to adefovir dipivoxil (ADV) in Chinese patients with chronic hepatitis B (CHB), including the normalization of alanine aminotransferase (ALT) levels.", "results_summary": "TDF demonstrated superior viral suppression compared to ADV in both HBeAg-positive and HBeAg-negative patients, with high rates of ALT normalization (>85%) and no observed resistance to TDF. Adverse event frequencies were comparable between treatment arms.", "population_specificity": "Chinese patients with chronic hepatitis B (HBeAg-positive and HBeAg-negative).", "effective_dosage": "TDF 300 mg once daily or ADV 10 mg once daily.", "study_duration": "48 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:40:58.539729+00:00"}
{"study_id": 105014, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were evaluating the efficacy and safety of crizotinib, not Alanine, in patients with ALK-positive non-small cell lung cancer.", "results_summary": "The study found that crizotinib demonstrated extended survival and improved response rates in patients with ALK-positive NSCLC, with common adverse effects including mild visual disturbances, nausea, and reversible liver enzyme elevations.", "population_specificity": "Patients with locally advanced or metastatic ALK-positive non-small cell lung cancer.", "effective_dosage": "Not mentioned (study focused on crizotinib, not Alanine).", "study_duration": "Not mentioned (study focused on crizotinib, not Alanine).", "interactions": "None mentioned (study focused on crizotinib, not Alanine).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:00.360175+00:00"}
{"study_id": 105015, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study aimed to assess the efficacy and safety of trabectedin for advanced breast cancer, not Alanine.", "results_summary": "The study did not evaluate Alanine's effects; it focused on trabectedin's impact on advanced breast cancer.", "population_specificity": "Women with advanced breast cancer previously treated with \u2264 2 lines of chemotherapy.", "effective_dosage": "Not applicable (study focused on trabectedin, not Alanine).", "study_duration": "Not applicable (study focused on trabectedin, not Alanine).", "interactions": "None mentioned (study focused on trabectedin, not Alanine).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:00.669555+00:00"}
{"study_id": 105016, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to assist physicians in assessing HBeAg-negative individuals using liver biopsy or non-invasive tools, including alanine transaminase (ALT), to identify disease progression and determine the need for anti-viral therapy.", "results_summary": "The abstract highlights the role of ALT in monitoring liver disease status but emphasizes the need for further evaluations to determine treatment necessity. It suggests using additional tools like hepatitis B s antigen quantification and transient elastography alongside ALT and HBV DNA for better patient classification.", "population_specificity": "HBeAg-negative individuals with chronic hepatitis B.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:00.848448+00:00"}
{"study_id": 105017, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of propofol and isoflurane anesthesia on postoperative liver function, including alanine aminotransferase levels, in patients undergoing posterolateral thoracotomy.", "results_summary": "The study found mild changes in postoperative liver enzyme levels, including alanine aminotransferase, within each group, but no significant differences between propofol and isoflurane anesthesia. Both anesthetics had comparable minor effects on liver function.", "population_specificity": "88 patients aged 16-60 years, ASA physical status 1 or 2, undergoing elective posterolateral thoracotomy.", "effective_dosage": "Not specified", "study_duration": "Measurements taken before anesthesia and on the first and third postoperative days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:03.358859+00:00"}
{"study_id": 105019, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of weight loss on liver fat, volume, and histology in patients with NASH, including changes in alanine aminotransferase levels.", "results_summary": "The study found no significant changes in alanine aminotransferase levels despite weight loss, though liver fat and volume decreased in patients with at least a 5% BMI reduction.", "population_specificity": "43 adult patients with biopsy-proven nonalcoholic steatohepatitis (NASH).", "effective_dosage": "Not specified", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:04.043319+00:00"}
{"study_id": 105018, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether combining rhubarb with early enteral nutrition (EEN) improved gastrointestinal function, systemic inflammation, and liver/kidney function in severe acute pancreatitis (SAP) patients, with a focus on alanine aminotransferase levels as a marker of liver damage.", "results_summary": "The combination of EEN and rhubarb significantly improved gastrointestinal function, reduced systemic inflammation (lowered CRP and IL-6, increased IL-11), and mitigated liver and kidney damage (reduced alanine aminotransferase, aspartate aminotransferase, and creatinine levels). Patients in this group also had shorter hospital stays and faster recovery.", "population_specificity": "126 patients with severe acute pancreatitis (SAP).", "effective_dosage": "Not specified for alanine; rhubarb was administered before EN (2 hours later).", "study_duration": "Not explicitly stated, but outcomes were longitudinally analyzed.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:05.477270+00:00"}
{"study_id": 105020, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to determine the maximum tolerated dose and preliminary efficacy of concurrent hepatic arterial infusion of floxuridine and systemic m-FOLFOX6 in Chinese patients with unresectable hepatic metastases from colorectal cancer.", "results_summary": "The study found dose-limited toxicities including alanine aminotransferase/aspartate aminotransferase elevation (5.7%). The overall response rate was 68.6% for hepatic metastases.", "population_specificity": "Chinese patients with unresectable liver metastases from colorectal cancer, with or without extrahepatic disease.", "effective_dosage": "0.12 mg/kg/day of FUDR combined with systemic m-FOLFOX6.", "study_duration": "Each cycle was repeated every 4 weeks (specific total duration not stated).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:06.490245+00:00"}
{"study_id": 105024, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not focus on Alanine but rather discusses alcoholic liver disease (ALD) and its diagnosis.", "results_summary": "The abstract does not report any findings related to Alanine.", "population_specificity": "Patients with clinical features of hepatitis, chronic liver disease, or elevated transaminase levels.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:07.240275+00:00"}
{"study_id": 105021, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to review the biological roles of DPP4, focusing on its enzymatic cleavage of proteins containing alanine or proline, and the mechanisms of DPP4 inhibitors in glucoregulatory, anti-inflammatory, and cardiometabolic actions.", "results_summary": "The study reviewed DPP4's role in cleaving proteins with alanine or proline, generating bioactive moieties, and highlighted the pleiotropic actions of DPP4 inhibitors in preclinical and clinical studies, including glucoregulatory and anti-inflammatory effects.", "population_specificity": "Preclinical and clinical studies (not specified further).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:08.056027+00:00"}
{"study_id": 105022, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate the relationship between low immediate postoperative platelet count and perioperative outcomes, including hepatic insufficiency, in HCC patients undergoing liver resection.", "results_summary": "The study found that low immediate postoperative platelet count was associated with higher rates of complications, liver failure, hepatic insufficiency, and mortality, and was an independent risk factor for hepatic insufficiency. Alanine aminotransferase levels and bilirubin were also higher in patients with low platelet counts.", "population_specificity": "565 consecutive hepatitis B-related hepatocellular carcinoma (HCC) patients who underwent major liver resection.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:08.257181+00:00"}
{"study_id": 105023, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate how gender, age, and lifestyle factors (alcohol, BMI, coffee, smoking) influence serum alanine aminotransferase (ALT) levels.", "results_summary": "The study found that ALT levels were significantly influenced by alcohol use and BMI, with age affecting ALT in men but not women. Interactions between alcohol use, BMI, and age were also observed, particularly in men.", "population_specificity": "6,269 apparently healthy individuals (2,851 men, 3,418 women, aged 25-74 years) from a national cross-sectional health survey.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Alcohol, BMI, smoking, and coffee consumption showed significant interactions with ALT and GGT levels.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:09.058234+00:00"}
{"study_id": 105025, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the diagnostic accuracy of noninvasive fibrosis assessment, including alanine aminotransferase (ALT)-related indices, for predicting advanced fibrosis or cirrhosis in Asian patients with hepatitis C.", "results_summary": "The study found that Fib-4 and Lok index, which incorporate ALT levels, were useful noninvasive indices for predicting advanced fibrosis and cirrhosis, with significant correlations to METAVIR stages. ARFI elastography also showed acceptable diagnostic performance for hepatic fibrosis assessment.", "population_specificity": "101 antiviral treatment-naive Asian patients with hepatitis C, aged 25-82 years.", "effective_dosage": "Not specified", "study_duration": "Enrollment occurred between March 2011 and March 2013, but intervention duration is not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:12.597480+00:00"}
{"study_id": 105027, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers were assessing the efficacy and safety of bosutinib versus imatinib in newly diagnosed chronic phase chronic myeloid leukaemia (CP-CML) patients, not specifically evaluating alanine.", "results_summary": "The abstract does not discuss alanine's effects; it focuses on bosutinib's efficacy and safety compared to imatinib in CP-CML patients.", "population_specificity": "Newly diagnosed chronic phase chronic myeloid leukaemia (CP-CML) patients.", "effective_dosage": "Not mentioned (for alanine).", "study_duration": "Not mentioned (for alanine).", "interactions": "None mentioned (for alanine).", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:13.623126+00:00"}
{"study_id": 105026, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The study aimed to analyze clinical characteristics, treatment, and outcomes of Kawasaki Disease (KD) patients associated with macrophage activation syndrome (MAS), comparing two diagnostic standards (HLH 2009 and Ravelli\u2019s criteria).", "results_summary": "The study found that alanine aminotransferase (ALT) increased significantly in seven out of eight KD patients with MAS, indicating liver dysfunction, but did not assess alanine's therapeutic effects or safety.", "population_specificity": "Children with Kawasaki Disease (KD) treated at The Children\u2019s Hospital, Zhejiang University School of Medicine (81.3 \u00b1 49.4 months, all male).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:13.740329+00:00"}
{"study_id": 105028, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to identify predictors for the duration of mechanical ventilation in patients with severe carbon monoxide poisoning and acute respiratory failure, including the role of alanine aminotransferase levels.", "results_summary": "Elevated alanine aminotransferase levels were statistically significant in the non-early extubation group, suggesting a potential association with prolonged mechanical ventilation. The study did not focus on alanine's therapeutic effects but noted its role as a biomarker.", "population_specificity": "Patients with severe carbon monoxide poisoning and acute respiratory failure requiring mechanical ventilation.", "effective_dosage": "Not available", "study_duration": "Not applicable (retrospective observational study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:16.226375+00:00"}
{"study_id": 105029, "supplement_id": 863, "safety_score": "70", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess the safety and efficacy of teriflunomide, including its effects on alanine aminotransferase levels, in patients with early multiple sclerosis.", "results_summary": "The study found that teriflunomide increased alanine aminotransferase levels in 19% of patients at the 14 mg dose and 17% at the 7 mg dose, compared to 14% in the placebo group. Serious adverse events related to alanine aminotransferase were rare (2% in both teriflunomide groups vs. 2% in placebo).", "population_specificity": "Patients aged 18-55 years with clinically isolated syndrome suggestive of multiple sclerosis.", "effective_dosage": "14 mg and 7 mg once daily.", "study_duration": "Up to 108 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:17.653577+00:00"}
{"study_id": 105030, "supplement_id": 863, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and efficacy of telbivudine (LdT) and lamivudine (LAM) in late pregnancy for preventing hepatitis B mother-to-child transmission (MTCT) in highly viremic mothers.", "results_summary": "The study found that LdT and LAM significantly reduced HBV DNA levels in mothers and MTCT rates compared to no treatment, with no significant safety concerns or differences in infant outcomes between treated and untreated groups. Alanine aminotransferase flares were more common in treated mothers but did not lead to severe adverse effects.", "population_specificity": "Hepatitis B e antigen-positive mothers with HBV DNA >6 log10 copies/mL in China.", "effective_dosage": "Not specified (treatment administered from gestation week 28 until postpartum week 4).", "study_duration": "From gestation week 28 until postpartum week 4.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:17.693172+00:00"}
{"study_id": 105031, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to understand the role of the glycine-alanine repeat (GAr) within EBNA1 in suppressing antigen presentation to the MHC class I pathway and its potential as a target for immune-based therapies against EBV-carrying cancers.", "results_summary": "The study found that the GAr sequence in EBNA1 suppresses antigen presentation by interfering with mRNA translation initiation, not at the protein level, which helps virus-carrying host cells evade the immune system. This mechanism has become a focus for developing immune-based therapies, with some lead compounds identified that affect GAr-carrying mRNA translation.", "population_specificity": "EBV-carrying cells and potential therapeutic targets for EBV-carrying cancers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:17.926185+00:00"}
{"study_id": 105032, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 64, "quality_score": 78, "study_goal": "The researchers aimed to compare the diagnostic accuracy of plasma M30 (CK18Asp396) with serum alanine aminotransferase (ALT) and other biochemical markers for detecting non-alcoholic steatohepatitis (NASH) in multi-ethnic Asian subjects with NAFLD.", "results_summary": "Serum ALT, AST, and GGT levels were significantly higher in NAFLD and NASH subjects compared to healthy controls and non-NASH subjects, respectively, while plasma M30 showed no significant difference between NASH and non-NASH subjects. The accuracy of ALT and AST for predicting NAFLD was high (AUROC 0.95 and 0.87), but their accuracy for NASH was moderate (AUROC 0.64 and 0.75).", "population_specificity": "Multi-ethnic Asian adults with biopsy-proven NAFLD (mean age 51.0 \u00b1 11.1 years, 51.6% male) and healthy controls (mean age 50.2 \u00b1 16.4 years, 33.3% male).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:20.544631+00:00"}
{"study_id": 105033, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to understand the mechanisms, clinical implications, and management strategies of hepatitis B flares, particularly focusing on the role of alanine aminotransferase (ALT) levels in these events.", "results_summary": "The study found that hepatitis B flares, marked by abrupt ALT level increases, result from immune responses against HBV and can lead to varying clinical outcomes, from asymptomatic cases to hepatic decompensation. Effective immune clearance during flares may lead to HBV seroclearance, while ineffective clearance requires immediate antiviral therapy.", "population_specificity": "Patients with chronic hepatitis B virus (HBV) infection, including those with cirrhosis or undergoing immunosuppression/chemotherapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:21.081727+00:00"}
{"study_id": 105034, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to examine the association between changes in HBsAg levels and treatment response in chronic hepatitis B (CHB) patients, including the role of alanine aminotransferase (ALT) levels.", "results_summary": "The study found that HBsAg decline was more pronounced in HBeAg-positive patients, particularly those with genotype A or elevated baseline ALT, and those who achieved HBeAg loss. Changes were similar across treatment groups and age categories.", "population_specificity": "Nucleos(t)ide-na\u00efve patients with HBeAg-positive or -negative chronic hepatitis B.", "effective_dosage": "Entecavir 0.5mg daily alone or combined with tenofovir 300 mg daily.", "study_duration": "100 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:21.856426+00:00"}
{"study_id": 105035, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to investigate the relationship between HCV viral load, psoriatic activity, and alanine aminotransferase (ALT) levels in patients with concomitant HCV infection and psoriasis vulgaris.", "results_summary": "The study found a significant correlation between the PASI score (psoriasis severity) and ALT levels, as well as HCV viral load, suggesting a potential interplay between HCV infection, liver dysfunction, and psoriasis severity.", "population_specificity": "Egyptian patients with concomitant psoriasis vulgaris and HCV infection.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:22.412000+00:00"}
{"study_id": 105036, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aimed to assess the efficacy and safety of tocilizumab (TCZ) combined with methotrexate/placebo in rheumatoid arthritis patients, including monitoring alanine aminotransferase elevations.", "results_summary": "The study found that alanine aminotransferase elevations >3\u00d7upper limit of normal were more frequent in patients receiving TCZ plus methotrexate (14.3%) compared to those switching to TCZ plus placebo (5.4%).", "population_specificity": "Patients with active rheumatoid arthritis despite methotrexate treatment.", "effective_dosage": "Not specified for alanine.", "study_duration": "3-year trial with TCZ discontinuation assessed over 1 year.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:24.389335+00:00"}
{"study_id": 105037, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate predictors and predictive models of histological progression and clinical outcomes for patients with chronic hepatitis C (CHC), including the role of alanine aminotransferase (ALT).", "results_summary": "The study found that baseline alanine aminotransferase (ALT) levels, along with other markers like AST/ALT ratio, were consistent predictors of clinical outcomes in CHC patients. However, the predictive models developed were not externally validated.", "population_specificity": "Patients with chronic hepatitis C (CHC) from 20 unique cohorts (5817 patients total).", "effective_dosage": "Not specified", "study_duration": "Median follow-up ranged from 2.5 to 14.4 years depending on the outcome measured.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:26.484371+00:00"}
{"study_id": 105038, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to examine the safety and tolerability of valacyclovir in veterans with herpes simplex virus type 2 and hepatitis C virus coinfection, including its effects on alanine aminotransferase (ALT) levels.", "results_summary": "Valacyclovir was not associated with toxicity or adverse events. ALT levels declined 6% to 10%, and HCV RNA levels were reduced by 24% during the valacyclovir phase, though the reduction was not statistically significant (P = 0.08).", "population_specificity": "U.S. veterans with genotype 1 HCV and herpes simplex virus type 2 coinfection.", "effective_dosage": "1 g twice daily", "study_duration": "8 weeks per phase (with a 2-week washout)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:27.443573+00:00"}
{"study_id": 105040, "supplement_id": 863, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were evaluating the effects of efavirenz (EFV) and tipranavir/ritonavir (TPV/r) on dolutegravir (DTG) pharmacokinetics, including potential impacts on alanine aminotransferase levels.", "results_summary": "Four subjects discontinued due to increased alanine aminotransferase levels linked to TPV/r. The study did not focus on alanine's effects but noted its role as a biomarker for liver toxicity.", "population_specificity": "Healthy subjects", "effective_dosage": "Not specified for alanine", "study_duration": "Varies by study arm (5-14 days)", "interactions": "None mentioned for alanine", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T19:41:29.040409+00:00"}
